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Abbreviations 
 
BSA: bovine serum albumin 
DMEM: Dulbecco’s modified eagle’s medium 
ECM: extracellular matrix 
EGF: epidermal growth factor 
FGF: fibroblast growth factor 
GAG: glycosaminoglycan 
GDNF: glial cell line-derived neurotrophic factor 
kDa: kilo Dalton 
mAb: monoclonal antibody 
MAM: meprin-A5 protein-receptor protein tyrosine phosphatase µ 
MAPK: mitogen-activated protein kinase 
MIDAS: metal ion-dependent adhesion site 
PBS: phosphate-buffered saline 
PE: phosphatydilethanolamine 
PI3K: phosphatidylinositol 3-kinase 
PMSF: phenylmethylsulfonyl fluoride 
RGD: arginine-glycine-aspartic acid 
SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
TBS: tris-buffered saline 
TGF: transforming growth factor 
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General introduction 
 
Multicellular organisms and Extracellular Matrix 
Multicellular animals are composed of numerous cells (about 60 trillions of cells in 
human) forming specialized tissues and organs. The life of an animal is maintained by 
complicated and exquisite functions of organs, which consist of a variety of tissues. In 
vertebrates, tissues can be grouped into four morphologically distinct components, i.e., 
nerve, muscle, epithelial and connective tissues, among which the epithelial and 
connective tissues are two majorities of the organization (Fig. 1). Individual tissues are 
ensembles of various types of cells that together execute specific functions. However, 
cells are not the only components to form tissues. Extracellular matrices (ECMs) also 
constitute the tissues to fill in the spaces among cells and to sculpture the tissue 
architectures. The ECM is evolutionarily ancient and present in all phyla of metazoans 
(Reichardt, 1999). The ECM had been defined morphologically as extracellular material 
visible as fibrils or sheets in the electron microscope, but now it is defined as more 
broadly to include almost all secreted molecules that are immobilized outside cells 
(Reichardt, 1999). 
The ECM is localized at the extracellular space of tissues, that is, basement 
membranes and the interstitial matrices. The basement membrane is a sheet-like structure 
constituted of ECM proteins, separating the epithelium from the connective tissues. Thus, 
the basement membrane is the only ECM directly associated with epithelial cells that 
play essential roles in individual organs (Fig. 1). The connective tissues are composed of 
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Fig. 1 A cross-sectional view of the wall of the intestine. This long tube-like organ (upper panel) is 
constructed from epithelial tissue (red), connective tissue (green), and muscle organ (yellow). Each tissue 
represents an organized assembly of cells held together by cell-cell adhesions, extracellular matrix or both 
(middle panel). Basement membrane is localized between epithelial and connective tissues (lower panel). 
(Middle and lower panels are cited from Alberts B. et al., Molecular Biology of the Cell, Fourth Edition, 
p.1066 and p.1090, respectively, 2002, Garland Science) 
GUT 
LUMEN OF GUT 
epithelium 
connective 
tissue 
circular 
fibers 
longitudinal 
fibers 
connective 
tissue 
epithelium 
smooth 
muscle 
epithelial 
cell 
fibroblast 
smooth 
muscle 
cells 
epithelial 
cell 
epithelium 
basement 
membrane 
macrophage 
fibroblast 
hyaluronic acid, 
proteoglycans, and 
glycoproteins 
collagen 
fiber 
capillary 
elastic fiber 
mast cell 
50 µm 
C
O
N
N
E
C
T
IV
E
 T
IS
S
U
E
 
 8 
vast majority of ECM molecules with sparsely scattered cells, and involved in the 
structure and support of the organizations. Formerly, the ECM had been thought to 
function merely as materials filling the spaces between cells. However, as the 
investigations proceeded, the ECM has been shown to play pivotal roles in cell survival, 
proliferation, and migration, and to be involved in diverse biological processes including 
organogenesis, thus regarded as an essential factor to regulate behaviors of the cells 
(Reichardt, 1999). The functions of the ECMs are now summarized as follows; 1) 
providing the mechanical integrity, rigidity, and elasticity for tissues to endure the force 
or impact of the surroundings; 2) providing adhesive substrates for cells to transmit 
adhesion signals that are essential for normal cells to survive; and 3) sequestering soluble 
factors, such as growth factors and morphogens, to help regulate the spatial and temporal 
properties of signals conveyed by these factors. 
 
Vertebrate ECMs 
Vertebrates possess various tissues that differ in their structures, functions, rigidity, 
and so on. Therefore, the ECMs exhibit clear diversity to be optimized for each tissue. 
Thus, the matrix can become calcified to form the rock-hard structures of bones or teeth, 
constitute the transparent matrix of the cornea, or adopt the rope-like organization that 
gives tendons their enormous tensile strength. To constitute such diverse structures, 
multiple combinations of ECMs should be used as to which individual tissues necessitate 
for their conditions. The ECMs are mainly composed of two classes of molecules: (1) 
polysaccharide chains of the class called glycosaminoglycans (GAGs), which are usually 
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found covalently linked to protein in the form of proteoglycans, and (2) fibrous proteins, 
including collagen, fibronectin and laminin, which have both structural and adhesive 
functions. 
 
The GAGs and proteoglycans 
  GAGs are unbranched polysaccharide chains composed of repeating dissacharides 
comprising a uronic acid and an amino sugar, which in most cases are sulfated (Fig. 2). 
Because of the presence of carboxylate groups in uronic acids and sulfate groups, GAGs 
are the most anionic molecules produced by animal cells. The differences in the kinds of 
the sugars, the types of linkage between sugars, and the number and location of sulfate 
groups give rise to four main groups of GAGs: (1) hyaluronic acid (also called as 
hyaluronan), (2) chondroitin sulfate, (3) heparan sulfate/heparin, and (4) keratan sulfate. 
Chondroitin sulfates are subdivided into five types; chondroitin sulfate-A, -B (commonly 
called as dermatan sulfate), -C, -D, and -E, by the differences in the uronic acid types 
(iduronic acid or glucuronic acid) or the number and location of the sulfate groups (Fig. 2 
B~F). 
Except for hyaluronic acid, all GAGs are found covalently attached to core protein. 
Such proteins with covalently attached GAGs are called proteoglycans. Proteoglycans 
are a set of ubiquitous proteins found on cell surface and in ECMs, and are defined by a 
common type of post-translational modification by GAGs (Lander, 1999). Some of the 
proteoglycans are summarized in Table 1. 
Proteoglycans are thought to have a major role in chemical signaling between cells.  
 10 
Fig. 2 The repeating disaccharide sequences of various GAGs. The chemical structures of the repeating 
disaccharide sequences of hyaluronic acid (A), chondroitin sulfate-A (B), dermatan sulfate (C), 
chondroitin sulfate-C (D), chondroitin sulfate-D (E), chondroitin sulfate-E (F), heparan sulfate (G), and 
keratan sulate (H) are shown. Sulfate groups are represented by red letters. Note that the sulfate groups 
and uronic acids are absent in hyaluronic acid and keratan sulfate, respectively.  
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proteoglycans bind to fibroblast growth factors (FGFs), which stimulate various types of 
cells to proliferate. The interaction of heparan sulfate chains with FGFs, as well as with 
FGF receptors, dimerizes the FGF receptors, thereby activating them on the cell surface 
(Harmer, 2006). Cell surface heparan sulfate proteoglycans, particularly syndecans, have 
been shown to serve as co-receptors for heparin-binding ECM proteins, including 
fibronectin, and help regulate focal adhesion formation and actin re-organization of cells 
(Couchman, 2003)  
 
Table 1. Some common proteoglycans (This table is cited from Alberts B. et al., Molecular Biology of 
the Cell, Fourth Edition, p. 1097, 2002, Garland Science, with minor modifications.) 
Proteoglycan Approximate 
molecular 
weight of 
core protein 
Type of GAG chains Number 
of GAG 
chains 
Location Functions 
Aggrecan 210,000 chondroitin sulfate + 
keratan sulfate 
~130 cartilage mechanical support; forms 
large aggregates with 
hyaluronic acid 
Betaglycan 36,000 chondroitin sulfate 1 cell surface 
and matrix 
binds transforming growth 
factor-β (TGF-β) 
Decorin 40,000 chondroitin sulfate 1 widespread 
in connective 
tissues 
binds to type I collagen 
fibrils and TGF-β 
Perlecan 600,000 heparan sulfate 2~15 basal laminae structural and filtering 
function in basal lamina 
Syndecans 20,000 
~45,000 
chondroitin sulfate + 
heparan sulfate 
1~3 cell surface cell adhesion; binds FGF 
and other growth factors 
Agrin 230,000 heparan sulfate 3 basal laminae formation of 
neuromuscular junctions 
 
The ECM proteins in connective tissues  
The connective tissues contain abundant ECM protein with sparsely scattered cells, 
typically fibroblasts. Many of the ECM proteins in the connective tissues form fibers, 
such as collagen and elastic fibers, to provide elasticity and rigidity of the tissues. 
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Fig. 3 The structure of a typical collagen molecule. A, a model of a part of a single collagen chain (left) 
and a triple-helix-formed three chains (right). One chain is composed of a series of Gly-Xaa-Yaa residues, 
so that the Gly can occupy the interior of the triple helix. B, a schematic model of the domains of a 
fibrillar procollagen molecule. (These figures are cited from; A, Alberts B. et al., Molecular Biology of the 
Cell, Fourth Edition, p.1097, 2002, Garland Science, and B, Kreis T. et al., Guidebook to the Extracellular 
Matrix, Anchor, and Adhesion Proteins, Second Edition, p.384, 1999, Oxford University Press.) 
 
Representatives of such ECM proteins are collagens. 
The collagens are the most abundant proteins in our body (about 25% of total proteins) 
secreted mainly by fibroblasts to form collagen fibers, contributing to the structural 
integrity of the ECMs. Collagen has characteristic three-residue repeats, Gly-Xaa-Yaa, in 
its primary structure, which results in a stable triple-helical conformation with the 
glycine residues at the core of the helix (Fig. 3). The triple-helical conformation provides 
collagens with rigid, rod-like structures. To date, 20 types of collagen family proteins has 
been identified, which can be divided into seven groups of collagens including fibrillar, 
fibrillar associated, short chain, basement membrane, multiplexin and membrane- 
associated ones, by their structures and functions (Table 2).  
  Some ECM proteins in connective tissues harbor strong cell-adhesive activity to  
A
glycine
1.5 nm
B
 13 
Table 2. Types of collagens and its distributions 
Groups Type Tissue distribution 
Fibrillar I 
 
II 
III 
V 
XI 
bone, skin, tendons, ligaments, cornea internal organs (accounts for 90% 
of body collagen) 
cartilage, invertebral disc, notochord, vitreous humor of the eye 
skin, blood vessels, internal organs 
as for type I 
as for type II 
Fibril-associated IX 
XII 
XVI 
XIX 
XX 
cartilage 
tendons, ligaments, some other tissues 
heart, kidney, intestine, ovary, testis, eye, arterial walls 
brain, eye, testis (ubiquitously expressed in embryo but less in adult) 
cornea 
Short chain VIII 
 
X 
capillary blood vessels, dermis around hair follicles, perichondrium, 
connective tissue surrounding nerve bundles 
bone 
Basement membrane IV basal lamina 
Multiplexin XV 
 
XVIII 
smooth muscles in blood vessels, beneath stratified squamous epithelia, 
kidney, testis, ovary, intestine  
basal lamina around blood vessels 
Membrane-associated XIII 
XVII 
eye, epidermis, hair follicles, endomysium 
hemidesmosomes 
Others VI 
VII 
Tendon 
beneath stratified squamous epithelia 
 
contribute to cell spreading and migration. Fibronectin is one of the representative ECM 
proteins that have strong cell-adhesive activities. Fibronectin is a high molecular-weight 
glycoprotein found in many extracellular matrices and in blood plasma of all vertebrates. 
Fibronectin is secreted as a dimer of two subunits held together by a pair of disulphide 
bonds near their C-termini (Fig. 4). Each subunit of fibronectin is made up largely of 
repeating modules of three types, 12 x type I, 2 x type II, and at least 15 x type III repeats 
(Fig. 4A), giving rise to many functional domains such as fibrin-binding, 
collagen-binding, heparin-binding, and cell-adhesive domains. Among these functional 
domains, the structure and function of cell-adhesive domain has been extensively 
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investigated. The cell adhesive activity of fibronectin has been shown to be reproduced 
by tripeptide sequence, Arg-Gly-Asp (RGD), located on the 10th fibronectin type III 
repeat at the center of fibronectin molecule (Pierschbacher and Ruoslahti, 1984). The 
RGD motif is positioned at the top of the loop protruding from the molecular surface of 
fibronectin (Leahy et al., 1996; Copie et al., 1998; Fig. 4C). In addition to the RGD motif, 
residues located on the 9th type III repeat, so called synergy site, has been shown to 
enhance cell adhesive activity of fibronectin (see page 28). 
 
 
Fig. 4 Structure of fibronectin. A, module structure of one fibronectin subunit composed of three types 
of repeat. At three positions (EDA, EDB, and IIICS) alternative splicing produces variants in structure. 
The two cell-binding sites are recognized by different integrin receptors, i.e., α5β1 or α4β1 integrin. B, 
electron micrographs of individual fibronectin dimers shadowed with platinum; red arrows mark the 
C-termini. C, The 3D structure of two type III repeats as determined by X-ray crystallography (PDB-ID; 
1FNF). (B is cited from Alberts B. et al., Molecular Biology of the Cell, Fourth Edition, p.1097, 2002, 
Garland Science) 
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The ECM proteins in basement membranes 
Basement membrane is a flexible, thin (40-120 nm thick) sheet-like structure of 
specialized ECMs that underlie all epithelial cell sheets and tubes (Fig. 5). They also 
surround individual muscle cells, fat cells, and Schwann cells. Thus, all parenchymal 
cells, which play major roles of individual tissues and organs, directly attach to the 
basement membranes. The basement membranes play roles not only in contributing to 
the integrity of tissues but also in transmitting signals to attached cells for their survival, 
proliferation, polarity, differentiation, and migration. In the kidney glomerulus, a 
basement membrane lies between epithelium and endothelium, and filters blood to 
Fig. 5 The structure of basement membranes. A, 
three ways in which basement membranes are 
organized. Basement membranes (yellow) underlie 
epithelia, surround muscle cells, and are interposed 
between two cell sheets in the kidney glomerulus. B, 
scanning electron micrograph of the basement 
membrane in the cornea of a chick embryo. Some of 
the epithelial cells have been removed to expose the 
basement membrane. A network of collagen fibrils in 
the underlying connective tissue interacts with the 
lower face of the membrane. (B is cited from Alberts 
B. et al., Molecular Biology of the Cell, Fourth 
Edition, p.1106, 2002, Garland Science) 
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produce urine. Not only higher triploblastic animals, but also lower diploblastic animals, 
such as comb jellies (Ctenophore) and hydra (Cnidaria), possess basement membranes 
(Dewel, 2000), and therefore the basement membranes are thought to be prototypic 
ECMs. 
Basement membranes are primarily composed of four types of proteins, namely 
laminins, type IV collagens, nidogens (also called as entactin) and perlecan, although 
their precise composition varies from tissue to tissue and even from region to region in a 
continuous basement membrane. Laminin is a family of heterotrimeric cruciform 
glycoprotein composed of α, β, and γ chains (Fig. 6). Combinations of five α, three β, 
and three γ chains give rise to at least 12 laminin isoforms, most of which are capable of 
forming network structures by self-association through their N-terminal globular 
domains. The requirement of laminins in embryogenesis was clearly shown by 
homozygous mutation of the laminin-γ1 chain, a component of most laminin 
heterotrimers. These mice die at peri-implantation stage due to failure of endoderm 
 
Fig. 6 The strucuture of laminin. 
A, The subunits of a laminin-111 
(composed of α1β1γ1 chains) 
molecule. Three chains are 
disulfide-bonded into an 
asymmetric cruciform structure. B, 
electron micrographs of laminin 
molecules shadowed with platinum. 
(B is cited from Alberts B. et al., 
Molecular Biology of the Cell, 
Fourth Edition, p.1106, 2002, 
Garland Science) 
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differentiation, underscoring the critical importance of laminin in mice development 
(Smyth et al., 1999; Li et al., 2003). Type IV collagen has a more flexible structure than 
the fibrillar collagens. Their triple-stranded helix is interrupted in 26 regions, allowing 
the type IV collagen to make multiple bends. Type IV collagens also form individual 
network structures by self-association. Nidogens and perlecan interact with both laminin 
and type IV collagens to connect laminin- and type IV collagen-networks, thus forming 
high order meshwork structures of the basement membranes (Fig. 7). Since these four 
proteins exist in all mature basement membranes of our body, these proteins are 
fundamental and thought as constitutive basement membrane proteins (Timpl and Brown, 
1996).  
Not only the four basement membrane proteins, i.e., laminin, type IV collagen, 
 
Fig. 7 A model of the molecular structure of a basement membrane. The basement membrane is 
formed by specific interactions between the proteins laminin, type IV collagen, nidogen, and the 
proteoglycan perlecan. Sheet structures of laminin and type IV collagen, both of which are formed by 
self-assembly, are connected by nidogen and perlecan. 
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nidogen, and perlecan, but also many other proteins contribute to form basement 
membranes in vivo (Manabe et al., 2008). These proteins differ from the constitutive 
basement membrane proteins in their expression patterns. While the constitutive 
basement membrane proteins are expressed throughout the basement membranes in our 
body, expression and localization patterns of the other proteins are restricted in 
tissue-specific and developmentally regulated manners. Those spatiotemporally regulated 
proteins may determine specific functions of the basement membranes of individual 
tissues and organs. Many spatiotemporally regulated basement membrane proteins are 
abundantly expressed in developmental stages but decreased or diminished in adult 
tissues, implying critical roles of these basement membrane proteins in tissue 
morphogenesis. Some of the spatiotemporally regulated basement membrane proteins are 
summarized in Table 3. 
 
Table 3. Representatives of spatiotemporally regulated basement membrane proteins 
Name Tissue distributions* Phenotypes of knockout mice References 
Nephronectin kidney, lung, hair 
follicle, intestine, tooth 
germ, and so on 
kidney agenesis or hypoplasia Brandenberger et al., 
2001; Linton et al., 2007 
MAEG skin and hair follicle not reported Osada et al., 2005 
Fras1 skin, hair follicle, 
kidney, and lung 
Fraser syndrome (kidney 
agenesis, cryptophthalmos, 
syndactyly) 
McGregor et al., 2003; 
Vrontou et al., 2003 
QBRICK/Frem1 skin, hair follicle, 
kidney, and lung 
Fraser syndrome Smyth et al., 2004; 
Kiyozumi et al., 2005; 
2006 
Frem2 skin, hair follicle, 
kidney, and lung 
Fraser syndrome Jadeja et al., 2005; 
Timmer et al., 2005 
* major distribution patterns in mice at embryonic day 16.5 
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While much progress has been made in the studies of the constitutive basement 
membrane proteins, the studies of spatiotemporally regulated basement membrane 
proteins are just beginning as those proteins have been identified over the last decade. 
Nephronectin is one of the novel spatiotemporally regulated proteins found in only 
vertebrates (Brandenberger et al., 2001; Morimura et al., 2001). Nephronectin consists of 
N-terminal five epidermal growth factor (EGF)-like repeats, a central linker segment 
containing an RGD cell adhesion motif, and a C-terminal MAM domain (Fig. 8A). The 
alternative splicing gives rise to long- and short-isoforms, although the functional 
differences between them are still unclear. The RGD motif in the central linker segment 
of nephronectin is critical to interact with the cell surface receptor integrin 
(Brandenberger et al., 2001). Nephronectin is unique in its distribution patterns in vivo. 
In mouse embryos, nephronectin is predominantly located at basement membranes in 
kidneys, lungs, and hair follicles, where it is implicated in epithelial-mesenchymal 
interaction (Fig. 8B-D), suggesting that nephronectin may work as a mediator for 
epithelial-mesenchymal interactions (Brandenberger et al., 2001). Mice with 
homozygous null mutation of the nephronectin gene exhibited the absence of the 
interaction between ureteric bud epithelium and metanephric mesenchyme, resulting in 
severe kidney agenesis or hypoplasia due to the failure of glial cell-line derived 
neurotrophic factor (GDNF) expression of metanephric mesenchyme (Fig. 8E-G; Linton 
et al., 2007). Moreover, recent findings suggest that nephronectin is implicated in cell 
proliferation and cancer progression. Expression of nephronectin has been shown to 
precede proliferation of tubular epithelium in the recovery phase of acute tubular 
 20 
  
Fig. 8 Molecular structure 
and functions of 
nephronectin. A, domain 
structure of nephronectin. 
Nephronectin is composed of 
five EGF-like repeats, a 
linker segment (containing 
an RGD cell adhesive motif), 
and a MAM domain. Two 
alternative splicing sites are 
found before and after the 
first EGF-like repeat. B-D, 
distribution patterns of nephronectin in embryonic day 16.5 mice. B, localization of nephronectin in 
kidney. Strong signals for nephronectin are found at the basement membranes, especially stalk (arrow) and 
developing glomeruli (arrowhead). C, nephronectin distributions in lung. Strong signals are found at 
bronchial basement membranes (arrowheads). D, nephronectin distributions in skin and hair follicle. 
Nephronectin localizes at basement membranes of epidermis (arrows) and the tip of hair follicle 
(arrowheads). An asterisk represents the hair follicle. E-G, urogenital phenotypes of wild type (E) and 
nephronectin-/- (F and G) mice. Mice with homozygous null mutaion of nephronectin exhibited unilateral 
kidney agenesis and hypoplasia (F), or bilateral kidney agenesis (G). Asterisks represent the primodium of 
kidneys. Ki, kidney; Ad, adrenal gland; Ur, ureter; Ut, uterus; Bl, bladder; DA, dorsal aorta. (E-G are cited 
from Linton et al., 2007) 
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necrosis (Cheng et al., 2008). Loss of nephronectin expression has been shown to 
promote tumor progression in malignant melanoma, but to inhibit metastasis of breast 
cancer to lung, bone, and kidney (Eckhardt et al., 2005; Kuphal et al., 2008). Despite the 
physiological importance of nephronectin, especially in kidney morphogenesis, most of 
these findings are based on the data of gene expression or tissue distribution patterns of 
nephronectin, and therefore, little is known about the molecular characteristics of 
nephronectin since full-length nephronectin has not been purified yet. 
To clarify physiological functions, basement membrane proteins should be isolated 
and biochemically characterized. However, the basement membrane proteins interact 
with other ECM proteins and/or self-associate to form huge ECM structures in vivo. 
Moreover, the ECM proteins are frequently cross-linked by tissue transglutaminase 
(Griffin et al., 2002), making it difficult to purify them. Engelbreth-Holm-Swarm (EHS) 
tumor was a superb source of basement membrane proteins, since the tumor produces an 
amorphous matrix composed of abundant basement membrane proteins including laminin, 
nidogen, type IV collagen, and perlecan (Kleinman et al., 1982), thus enabling them to be 
purified (Yurchenco and O'Rear, 1994). Conditioned media of certain cell lines was also 
good sources to purify several laminin isoforms (Kikkawa et al., 1998; Fujiwara et al., 
2001). While the sources described above enable many of constitutive basement 
membrane proteins to be purified, most of spatiotemporally regulated basement 
membrane proteins have not been purified as intact proteins because the sources 
containing the spatiotemporally regulated basement membrane proteins are restricted. In 
the present study, to overcome this problem, I established recombinant expression 
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systems of the spatiotemporally regulated proteins (Chapter I). I expressed and purified 
recombinant full-length and domain-deleted mutants of nephronectin, and characterized 
functions of each domain of nephronectin by using these recombinant proteins. 
 
The receptors for ECMs 
To gain information from ECMs, receptor proteins are essential for cells to recognize 
the ECMs and to transmit signals into cells. Indeed, individual cells express a variety of 
ECM receptor proteins that are inherent to the cell types. A typical receptor protein is 
composed of three functional domains; an extracellular domain that interacts with ECM 
proteins, a transmembrane domain that are rich in hydrophobic amino acid residues to be 
anchored into lipid bilayer of plasma membranes, and an intracellular domain that 
interacts with various intracellular proteins such as adaptor proteins or kinases. The ECM 
receptors convert the information of ECMs to intracellular signals including 
phosphorylation of intracellular proteins and rearrangement of cytoskeletons, thereby 
  
Table 4. Representatives of ECM receptor proteins 
Protein/family name Number of 
isoforms* 
Protein type Ligand 
Integrin 24 heterodimeric glycoprotein most of cell adhesive ECM proteins  
Dystroglycan 1 Glycoprotein laminin 
Syndecan 4 heparan sulfate/chondroitin 
sulfate proteoglycan 
fibronectin, laminin, collagen etc. 
(heparin-binding ECM proteins) 
NG2 1 chondroitin sulfate  
proteoglycan 
collagen (type II, V, and IV), and 
laminin 
CD44/CSPG 1 Chondroitin sulfate 
proteoglycan 
type IV collagen and 
fibrin/fibrinogen 
* isoforms exsisting in mammals 
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regulating cell behaviors such as survival, proliferation, differentiation, and migration. 
Table 4 shows typical receptor proteins for ECMs. Among these ECM receptor proteins, 
an integrin family has critical roles in recognition of ECMs. 
 
The integrins : a family of receptor proteins for ECMs 
  The integrins form a large family of receptor proteins for cell adhesion to ECMs and, 
in vertebrates, also plays important roles in cell-cell adhesion (Hynes, 2002). They 
interact with various ligands including ECM proteins and receptor proteins expressed on 
the cell surface via a divalent cation-dependent manner (Mould et al., 1995). By 
integrating the information of extracellular proteins and the intracellular signaling 
cascades, integrins play mandatory roles in embryonic development, the maintenance of 
tissue architectures, immune responses, hemostasis, and many human diseases including 
cancer (Hynes, 1992; 2002). Integrins are found in all multicellular animals, including 
fruit fly, nematode, and even sponge (Muller, 1997; Johnson et al., 2009), indicating that 
the family evolved relatively early in the history of metazoans. 
Integrins are composed of two non-covalently associated subunits, termed α and β. 
Amino acid sequences and electron microscopic observations of purified integrin 
heterodimers revealed that integrins consist of a large extracellular domain with a 
globular head region and two long tails, each containing a transmembrane domain and a 
cytoplasmic domain (Nermut et al., 1988; Fig. 9A). In mammals, 18 α and 8 β subunits 
have been indentified, and the combinations of these subunits give rise to at least 24 
distinct integrin heterodimers, among which 18 integrin isoforms serve as receptors for 
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ECM proteins (Fig. 9B). The ligand-binding specificities of integrins are mainly 
determined by their α subunits. The integrins containing α1, α2, α10, and α11 subunits 
bind to collagens, while those containing α3, α6, and α7 are receptors for laminins. α5, 
α8, αIIb, and αV-containing integrins recognize the tripeptide sequence consisting of 
Arg-Gly-Asp in the ECM ligands. α4 and α9-containing integrins have been shown to 
interact with the sequences comprised of aliphatic residues adjacent to acidic residues, 
such as Leu-Asp-Val or Ile-Asp-Gly (Komoriya et al., 1991; Schneider et al., 1998; 
Yokosaki et al., 1998). The binding specificities of individual integrins show that each 
 
 
Fig. 9 The combinations of the integrins. A, a schematic model of integrin heterodimer. Integrins are αβ 
heterodimers; each subunit crosses the membrane once, with most of each polypeptide in the extracellular 
space and two short cytoplasmic domains. TM, transmembrane domain. B, The mammalian subunits and 
their αβ associations; 8 β subunits can assort with 18 α subunits to form 24 distinct integrins. These can 
be considered in several subfamilies based on evolutionary relationship, ligand-binding specificity and, in 
the case of β2 and β7 integrins, restricted expression on leucocytes. All but leukocyte-specific integrins 
are receptors for ECM proteins. The collagen-, LDV/IDG-binding, and leucocyte-specific integrins are 
restricted to chordates, as are subunits β2-β8. 
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Table 5. Integrin gene knockout phenotypes 
Subunits Lethality Phenotypes 
α1 viable, fertile No immediately obvious developmental defects, reduced tumor vascularization 
α2 viable, fertile Few immediately obvious developmental defects, delayed platelet aggregation 
and reduced binding to monomeric collagen, reduced mammary gland 
branching 
α3 perinatal 
lethal 
Kidney tubule defects, reduced branching morphogenesis in lungs, mild skin 
blistering, lamination defects in neocortex 
α4 E11/14 lethal Defects in placenta (chorioallantoic fusion defect) and heart (epicardium, 
coronary vessels) 
α5 E10-11  
lethal 
Defects in mesoderm (posterior somites) and vascular development, neural crest 
apoptosis 
α6 perinatal 
lethal 
Severe skin blistering, other epithelial tissues also defective. Lamination defects 
in cortex and retina. 
α7 viable, fertile Muscular dystrophy, defective myotendinous junctions 
α8 perinatal 
lethal 
Smaller or absent kidneys, inner hair cell defects 
α9 viable Die within 10 days of birth, chylothorax due to lymphatic duct defect 
α10 viable, fertile Growth retardation of the long bones due to moderate dysfunction of growth 
plate chondrocytes,  
α11 viable, fertile Dwarfism with increased mortality due to severely defective incisors 
αV E10/perinatal 
lethal 
Two classes: embryonic lethality due to placental defects, perinatal lethality 
with cerebral vascular defects probably due to neuroepithelial defects, cleft 
palate. 
αIIb viable, fertile Hemorrhage, no platelet aggregation 
αL viable, fertile Impaired leukocyte recruitment 
αM viable, fertile Defective phagocytosis and apoptosis of neutrophils, mast cell development 
defects, adipose accumulation 
αX viable, fertile Decreased longevity and survival rate upon infection with pneumococci, 
αD viable, fertile No immediately obvious developmental defects, reduced T cell response and 
phenotypic changes after induction by Staphylococcal enterotoxin 
αE viable, fertile Greatly reduced numbers of intraepithelial lymphocytes 
β1 E6.5  lethal Peri-implantation lethality, inner cell mass deteriorates, embryos fail to 
gastrulate 
β2 viable, fertile Leukocytosis, impaired inflammatory responses, skin infections, T cell 
proliferation defects 
β3 viable, fertile Hemorrhage, no platelet aggregation, osteosclerosis, hypervascularisation of 
tumors 
β4 Perinatal 
lethal 
Severe skin blistering, other epithelial tissues also defective 
β5 viable, fertile No immediately obvious developmental defects 
β6 viable, fertile Inflammation in skin and airways, impaired lung fibrosis, all probably due to 
failure to activate TGF-β 
β7 Viable Deficits in gut-associated lymphocytes-no Peyer’s patches, reduced 
intraepithelial lymphocytes 
β8 E10/ perinatal 
lethal 
Two classes: embryonic lethality due to placental defects, perinatal lethality 
with cerebral vascular defects probably due to neuroepithelial defects 
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integrin has a specific, non-redundant function. This is most clearly shown by the 
phenotypes of knockout mice (Table 5). To date, genes for all integrin α and β subunits 
have been knocked out, and each phenotype is distinct, reflecting the different roles 
among the various integrins. 
The integrin α8 subunit was originally identified in chick nerves, and assembled 
exclusively with β1 subunit (Bossy et al., 1991). Based on the homology of αV and α5 
subunits and the ligand-binding specificity, the α8β1 integrin is categorized into one of 
the RGD-recognizing integrins (Fig. 9B). The initial works on α8 integrin, based on 
tissue distribution pattern and in vitro data, suggested a role in neurite outgrowth (Bossy 
et al., 1991; Muller et al., 1995; Varnum-Finney et al., 1995). Mice deficient in α8 
integrin expression, however, displayed 
unexpected phenotypes. The mice showed 
severe kidney agenesis or hypoplasia, 
 
 
 
 
 
 
 
Fig. 10 Kidney phenotype in α8-deficient mice on 
the day of birth. The urogenital tract was dissected 
from wild type (A) or α8-deficient (B-D) mice. Mice 
deficient in α8 integrin expression showed bilateral 
kidney agenesis (B) or unilateral kidney agenesis and 
hypoplasia (C). (D) High magnification view of a 
kidney rudiment (asterisk, boxed in C). ad, adrenal 
grands; k, kidneys; u, ureter; b, bladder, t, testis; da, 
dorsal aorta; uh, uterine horns. Scale bars, 100 µm. 
(These figures are cited from Müller et al., 1997) 
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possibly due to the defect of the epithelial-mesenchymal interaction between ureteric bud 
epithelium and metanephric mesenchyme (Muller et al., 1997; Fig. 10). Since the α8β1 
integrin is expressed in metanephric mesenchyme and accumulates at the basement 
membrane underlying the ureteric bud epithelium (Fig. 11), it has been thought that the 
α8β1 integrin is necessary for the metanephric mesenchyme to receive signals from 
ureteric bud epithelium essential for kidney morphogenesis. To date, the α8β1 integrin 
has been shown to interact with various RGD-containing ECMs, including fibronectin, 
vitronectin, nephronectin, MAEG, and QBRICK/Frem1 (Muller et al., 1995; Schnapp et 
al., 1995; Brandenberger et al., 2001; Morimura et al., 2001; Kiyozumi et al., 2005; 
Osada et al., 2005). Among these ECM proteins, nephronectin is believed to be a 
physiological ligand for 
α8β1  i n t e g r i n  i n  t h e  
 
Fig. 11 Localization patterns 
of the integrin α8 subunit in 
t h e  d e v e l o p i n g  k i d n e y . 
Sections of E12.5 mice embryos 
were stained with antibodies 
against the extracellular domain 
of the integrin α8 subunit (red) 
and  neph ronec t in  (g reen ) . 
Nucle i  were  v isual ized  by 
s ta ining of  Hoechst  33342 
(blue). Arrowheads indicate the 
accumulation of mesenchymal 
in tegr in  α8 subuni t  a t  the 
basement membranes of ureteric 
b u d ,  w h e r e  t h e  b a s e m e n t 
membrane protein nephronectin 
deposits. Scale bar, 50 µm. 
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developing kidney, because the distribution patterns and the phenotypes of gene 
knockout mice of nephronectin are similar to those of the integrin α8 subunit 
(Brandenberger et al., 2001; Linton et al., 2007; Figs. 8, 10, and 11). However, it is still 
unclear why other ligands for the α8β1 integrin, such as fibronectin, failed to 
compensate the loss of nephronectin expression. 
 
 
The mechanisms of ligand recognition by integrins 
The discovery that opened the door to the study of integrin biochemistry was the 
identification of the cell adhesive sequence from fibronectin. The adhesive motif was 
initially discovered by Pierschbacher and Ruoslahti (1984); the adhesive capacity of 
fibronectin was mimicked by a small synthetic peptide containing the RGD sequence. 
Subsequently, several other peptide ligands or residues critical for integrin interactions 
have been identified, as shown in Table 6. Thus, αIIbβ3 integrin binds to the C-terminal 
peptide of γ chain of fibrinogen, containing KQAGDV sequence, in addition to the RGD 
motif (Calvete et al., 1992; Springer et al., 2008). The collagen-binding integrin α2β1 
has been shown to  interact with the sequence comprised of GFOGER (where “O” 
represents hydroxyproline) (Knight et al., 1998). It is noteworthy that all of these peptide 
ligands have an acidic residue, i.e., aspartate or glutamate. In nearly all instances, this 
residue is essential for function, suggesting that the acidic residue of the ligand is a 
conserved binding residue throughout the integrin family (Smith, 1994). Although 
peptide ligands have not been identified in the laminin-binding integrins, several studies 
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demonstrated that the Glu residue at the third position from the C-termini of the laminin 
γ chains is critically important in the recognition of laminins by integrins (Ido et al., 
2007; 2008). 
 
Table 6. Integrin recognition sequences 
Integrin Representative adhesive 
ligand 
Peptide sequence Additional sequences required 
for affinity modulation 
α2β1 Collagen GFOGER  
α4β1 FN, VCAM-1 EILDV  
α9β1 Tenascin, VCAM-1 EIDG  
αVβ1 FN, VN RGD  
αVβ3 FN, VN, Fbg, OP RGD  
αVβ5 FN, VN RGD  
αVβ6 FN, LAP-TGFβ RGD LXXL/I (immediately after the 
RGD motif) 
α5β1 FN RGD PHSRN and other basic 
residues 
αIIbβ3 Fbg, FN, VN RGD, KQAGDV  
α8β1 FN, VN, OP, nephronectin  RGD  
αMβ2 Fbg, C3bi QKRLDGS  
α4β7 FN, VCAM-1, MAdCAM EILDV  
Abbreviations used are; FN, fibronectin; VCAM, vascular cell adhesion molecule; VN, vitronectin; Fbg, 
fibrinogen; OP, osteopontin; LAP-TGFβ, latency-associated peptide of transforming growth factor β; 
MAdCAM, mucosal addressin cell adhesion molecule. The critical acidic residues are shown in bold. 
 
 
The elucidation of the mechanisms of ligand recognition by integrins is greatly 
progressed by determining the crystal structure of αVβ3 (Xiong et al., 2001; 2002; Fig. 
12A) and αIIbβ3 integrins (Xiao et al., 2004; Springer et al., 2008). The structures of 
integrins complexed with cyclic RGD peptide and ligand-mimetic compounds revealed 
that the arginine side chain (or a basic moiety) of the RGD motif fits into a groove of the 
β-propeller domain of integrin α subunits, whereas the carboxylate group of the aspartate 
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side chain coordinates the divalent cation at the metal ion-dependent adhesion site 
(designated MIDAS) (Fig. 12B and C). It is conceivable that the coordination of the 
carboxylate group to the divalent cation is essential for all integrins to interact with 
ligands, because all of the peptide ligands identified thus far have had at least one acidic 
residue (aspartate or glutamate; see Table 6) and, more importantly, all of the 
integrin-ligand interfaces analyzed thus far revealed that the divalent cation at the 
MIDAS serves as the central anchor point of ligands for integrins (Takagi, 2007). Despite 
that the acidic residues of ligands for all integrins are conserved and prerequisite, 
arginine residues are not conserved except for those for RGD-binding integrins. For 
example, α4β1- and α9β1-targeted peptide ligands and compounds bear an aliphatic 
moiety adjacent to the acidic residue (Mould et al., 1991; Schneider et al., 1998; Liu et 
al., 2006; Peng et al., 2006). These residues adjacent to the acidic moiety that coordinates 
the divalent cation at the MIDAS may determine the specificities of ligand recognition 
by integrins, as the arginine side chain of the RGD peptide forms a salt bridge to the 
β-propeller of α subunit, which predominantly determines the ligand-binding 
specificities. 
Although the specificities of ligand recognition by integrins are primarily determined 
by the short amino acid motifs, some residues outside the motifs can define the binding 
specificities as well as affinities toward individual integrins (Ruoslahti, 1996; Takagi, 
2004). Those affinity-modulating sequences are extensively investigated in RGD-binding 
integrins, as shown in Table 6. The α5β1 integrin is well known for its potency to bind 
specifically to fibronectin among the many RGD-containing ECM proteins. The binding  
 31 
 
Fig. 12 Structure of the extracellular 
segment of αVβ 3 integrin. A, a ribbon 
drawing of crystallized αVβ3 integrin. Integrin 
αV and β3 subunits are shown in blue and red, 
respectively. Integrin αV subunit is composed 
of an N-terminal β-propeller domain, a thigh 
domain, and two calf domains, whereas β3 
subunit consists of a βA domain, a hybrid 
domain, a PSI (plexins, semaphorins, and 
integrins) domain, four EGF-like repeats, and a β terminal domain (βTD). B, surface representation of the 
ligand-binding site of αVβ3 integrin, with the cyclic RGD-containing peptide shown as ball-and-stick 
model. The peptide ligand is bound at the β-propeller-βA domain interface. The Mn2+ ions at MIDAS and 
adjacent to MIDAS (ADMIDAS) are shown as a cyan and a violet spheres, respectively. The carbon, 
nitrogen, and oxygen atoms of cyclic RGD peptide are shown in yellow, blue, and red, respectively. C, 
interactions between ligand and integrin. The peptide and residues interacting with the ligand or with Mn2+ 
ions are shown in ball-and-stick representation. Hydrogen bonds and salt bridges are represented with 
dotted lines. (A is cited from Xiong, et al., 2001; B and C are cited from Xiong, et al., 2002.) 
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specificity of α5β1 integrin is determined not only by the RGD motif in the 10th type III 
repeat, but also by the PHSRN sequence within the preceding 9th type III repeat, the 
latter serving as a so-called “synergistic binding site” (Aota et al., 1994; Redick et al., 
2000; see Fig. 4). The αVβ6 integrin has also been shown to require both the RGD motif 
and the LXXL/I sequence for its high-affinity binding to its ligands, e.g., latency- 
associated peptide of TGFβ and coat protein of foot-and-mouth disease virus (DiCara et 
al., 2007). In addition to the RGD-binding integrins, several laminin-binding integrins 
has been shown to recognize the C-terminal 20 amino acid residues of laminin β2 chain, 
thereby enhancing its binding affinities to laminins containing β2 chain (Taniguchi et al., 
2009). The mechanisms by which these additional residues increase the binding affinities 
to individual integrins are still poorly understood. However, it is conceivable that these 
residues serve as auxiliary binding sites to integrins or exert a fine-tuning effect on the 
active conformation of the short amino acid motifs, such as the RGD motif, primarily 
required for the interactions. 
The binding specificities of individual integrins provide insights into not only the 
physiological ligands for but also the physiological functions of each integrin. As shown 
above, however, the information about amino acid sequences of each integrin provides, if 
any, the types of the integrin (i.e., RGD- or laminin-type) but is incapable of determining 
the physiological ligands, since the additional residues in the ligands, such as the synergy 
site of fibronectin, facilitate the interaction of individual integrins with specific ligands. 
Therefore, it is necessary that the ligand-binding specificities of individual integrins 
should be tested one by one, with appropriate systems to assess. About a decade ago, the 
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binding specificities of integrins were mainly determined by inhibition assay of cell- 
adhesion activities to ligands with function-blocking antibodies against individual 
integrins (Kikkawa et al., 2000; Fujiwara et al., 2001). These cell-based assays are hard 
to analyze the affinities of integrin-ligand interactions, because individual cells express a 
series of integrins that bind to the same ligand with a different affinity. The binding assay 
with purified recombinant integrin is suitable to overcome these problems. For example, 
purified recombinant α5β1 integrin enables us to analyze the kinetics of the real-time 
interaction of integrin α5β1 with fibronectin (Takagi et al., 2003). A series of purified 
laminin-binding integrins provide the comprehensive survey of binding affinities as well 
as specificities of individual integrins to a series of laminin isoforms (Nishiuchi et al., 
2006). These studies strongly demonstrate that recombinant integrins are powerful tools 
to determine ligand-binding specificities of the integrins. 
 
Based on the backgrounds described above, I tried to clarify the following questions: 
1. What is the role of individual domains of nephronectin? Are there any proteins/ 
molecules bound to individual domains of nephronectin? 
2. Does α8β1 integrin, one of the known receptors for nephronectin, selectively interact 
with nephronectin? If so, what determines the binding selectivity of nephronectin to 
α8β1 integrin?  
 
To solve the first question, I expressed and purified recombinant nephronectin and its 
deletion mutants, then examined their binding activities toward a panel of GAG chains 
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and α8β1 integrin. In this study, I found that nephronectin strongly binds to 
heparin/heparan sulfate and chondroitin sulfate-E. Domain deletion mutants revealed that 
nephronectin mainly interact with heparin/heparan sulfate and chondroitin sulfate-E 
through the MAM domain and the EGF-like repeats, respectively. Although the central 
linker segment of nephronectin has no binding activity to GAG chains I tested, the linker 
segment harbors potent activity to interact with recombinant α8β1 integrin. These results 
indicated, for the first time, that nephronectin interacts with heparan and chondroitin 
sulfate proteoglycans through its MAM domain and EGF-like repeats, respectively, while 
the linker segment serves as a recognition site for α8β1 integrin. It is also the first case 
that distinct domains of one protein independently interact with GAGs, one to 
heparin/heparan sulfate and the other to chondroitin sulfate-E. These results are shown in 
Chapter I. 
 
To solve the second question, I examined the binding activities of recombinant α8β1 
integrin to a panel of RGD-containing ECM proteins and deletion mutants of 
nephronectin as well as full-length nephronectin. While the central linker segment as 
well as full-length nephronectin possesses potent activities to bind to α8β1 integrin, 
other RGD-containing ECM proteins, known to interact with α8β1, exhibited only 
marginal activities. A variety of deletion mutants of the linker segment of nephronectin 
revealed that the linker segment harbors two motifs required for potent interaction with 
α8β1 integrin, one containing the RGD motif and the other serving as an auxiliary 
binding site. The details are shown in Chapter II. 
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Chapter I 
 
 
Characterization of Domain Functions 
of Nephronectin 
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I-1 Summary 
 
Nephronectin is a novel basement membrane protein mainly expressed in embryonic 
kidney, and is shown to be involved in kidney development. The known receptor for 
nephronectin is α8β1 integrin, which is also implicated in the epithelial-mesenchymal 
interaction in the developing kidney. Despite the importance of nephronectin as a 
regulator of kidney morphogenesis along with α8β1 integrin, little is known about 
molecular properties of nephronectin. In the present study, I produced and purified a 
recombinant nephronectin and its deletion mutants using a mammalian expression system 
to elucidate the domain functions of nephronectin, with special reference to their binding 
abilities towards a panel of GAGs. Among the GAGs tested, nephronectin strongly bound 
to heparin and chondroitin sulfate-E and moderately to heparan sulfate. Using the 
deletion mutants of nephronectin, I found that nephronectin mainly bound to 
heparin/heparan sulfate through the MAM domain, whereas to chondroitin sulfate-E 
through the EGF-like repeats. Although the central linker segment exhibited no 
GAG-binding activity, it was capable of strong binding to α8β1 integrin with an activity 
comparable to that of full-length nephronectin. These results suggest that N-terminal five 
EGF-like repeats and C-terminal MAM domain interact with chondroitin sulfate and 
heparan sulfate proteoglycans, respectively, while the central linker segment is 
responsible for potent interaction of nephronectin with α8β1 integrin. 
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I-2 Introduction 
 
  The interactions of cells with ECM proteins are critically important in regulation of 
cell behaviors such as survival, proliferation, migration, and differentiation (Roskelley et 
al., 1995). These interactions occur through the cell surface receptors such as integrins 
and membrane-bound proteoglycans, thereby transmitting signals into cells. In epithelial 
cells, the ECM proteins directly attached to cells are located in the basement membrane. 
The basement membrane is composed mainly of laminins, type IV collagens, nidogens, 
and perlecan (Timpl and Brown, 1996). In addition to these proteins, basement 
membranes contain proteins expressed in developmental- and tissue-specific manners. 
These restricted proteins are thought to be involved in tissue- and organ-specific 
morphogenesis. 
  Nephronectin is one of the tissue-specific and developmentally restricted basement 
membrane proteins. It is composed of N-terminal five EGF-like repeats, a central linker 
segment containing RGD cell adhesive motif, and a C-terminal MAM domain 
(Brandenberger et al., 2001; Morimura et al., 2001). In developing kidney, nephronectin 
is selectively expressed in ureteric bud epithelial cells and located in the basement 
membranes under these cells (Brandenberger et al., 2001). The known receptor for 
nephronectin is integrin α8β1, which is expressed in metanephric mesenchymes in 
developing kidney and has been shown to play a crucial role in epithelial-mesenchymal 
interaction during early steps of kidney morphogenesis (Muller et al., 1997). 
Nephronectin interacts with α8β1 integrin through the RGD motif residing in the central 
 38 
linker segment of nephronectin. Mice deficient in nephronectin or α8 integrin expression 
were associated with a transient reduction in GDNF expression in the metanephric 
mesenchyme (Linton et al., 2007), exhibiting severe kidney agenesis or hypoplasia. The 
phenotypes of the mice deficient in nephronectin or α8 integrin expression lead to the 
hypothesis that the interaction between α8β1 integrin and nephronectin is critical for the 
expression of GDNF. Despite the importance of nephronectin as a regulator of kidney 
morphogenesis along with integrin α8β1, little is known about molecular properties of 
nephronectin. The functions of domains other than the RGD-containing linker segment in 
nephronectin, i.e., N-terminal five EGF-like repeats and C-terminal MAM domain, 
remain unexplored. 
  Proteoglycans, consisting of a protein core coupled to variably sulfated GAG chains, 
function as mediators of interactions between growth factors and their receptors through 
association of the GAG chain (Perrimon and Bernfield, 2000). The GAG chains of 
proteoglycans also interact with extracellular matrices as well as growth factors and their 
receptors, playing mandatory roles in storing and concentrating growth factors to 
regulate activation of growth factor receptors efficiently (Lander, 1999). In kidney 
morphogenesis, proteoglycans, especially heparan sulfate proteoglycans, are thought to 
play mandatory roles in generating a concentration gradient of growth factors and 
morphogens, such as FGFs (Allen et al., 2001; Clayton et al., 2001; Qiao et al., 2001), 
members of the TGF-β superfamily (Santos and Nigam, 1993; Sakurai and Nigam, 1997), 
GDNF (Barnett et al., 2002), pleiotrophin (Sakurai et al., 2001), BMPs (Grisaru et al., 
2001; Bush et al., 2004), Wnts (Kispert et al., 1996), and hedgehog (The et al., 1999), 
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thereby modulating their biological activities. A role of heparan sulfate proteoglycans in 
kidney development has also been investigated with mice homogeneously mutated in 
heparan sulfate 2-sulfotransferase gene that encodes an enzyme responsible for sulfation 
of uronic acid residues of heparan sulfate; these mutated mice show severe kidney 
agenesis (Bullock et al., 1998). Moreover, inhibition of sulfated GAG syntheses also 
results in impaired ureteric bud branching in ex vivo cultures of kidney primordia (Steer 
et al., 2004). 
  In the present study, I produced and purified recombinant mouse full-length 
nephronectin and its deletion mutants to examine its binding to GAG chains. 
Nephronectin binds to highly sulfated GAGs including heparin, heparan sulfate, and 
chondroitin sulfate-E. This heparin/heparan sulfate-binding activity is mainly due to in 
the MAM domain, while EGF-like repeats of nephronectin bind to chondroitin sulfate-E. 
In addition, I found that the central linker segment of nephronectin strongly interacts 
with α8β1 integrin, raising a possibility that α8β1 integrin and cell surface heparan 
and/or chondroitin sulfate proteoglycans cooperatively transmit signals responsible for 
organogenesis. These results suggest that nephronectin interacts with heparan sulfate and 
chondroitin sulfate proteoglycans through its MAM domain and EGF-like repeats, 
respectively. 
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I-3 Materials and Methods 
 
Materials and reagents—Human plasma fibronectin and vitronectin were purified 
from outdated human plasma by gelatin- and heparin-affinity chromatography, 
respectively, as described previously (Sekiguchi et al., 1983; Yatohgo et al., 1988). 
Human fibrinogen was purchased from Enzyme Research Laboratories Inc. (South Bend, 
IN). Antibodies against FLAG and 5xHis tags were obtained from Sigma (Saint Louis, 
MO) and QIAGEN (Hilden, Germany), respectively. HRP-conjugated donkey and goat 
anti-mouse IgG antibodies were obtained from Jackson ImmunoResearch laboratories 
Inc. (West Grove, PA) and American Qualex International Inc. (San Clemente, CA), 
respectively. Heparin-Sepharose beads were purchased from Amersham (Piscataway, NJ). 
Phosphatidylethanolamine-conjugated GAGs (PE-GAGs) were prepared as described 
previously (Sugiura et al., 1993). The mAb against human integrin α8 subunit was 
produced by fusion of Sp2 mouse myeloma cells with spleen cells from mice immunized 
with recombinant soluble integrin α8β1, and was selected by positive reactivity with 
recombinant integrin α8β1 and negative reactivity with recombinant integrin α5β1. The 
mAb 10A8 was capable of binding to integrin α8 subunit on immunoblots under both 
reducing and non-reducing conditions. 
Expression vectors—Mouse nephronectin cDNA was obtained from Dr. Yoshihide 
Hayashizaki (Riken, Japan). The cDNA was subcloned into pFLAG-CMV vector 
(Invitrogen) in frame to FLAG tag at the 3’ end. A cDNA fragment encoding 
nephronectin deleted for the MAM domain (NN-ΔMAM) was amplified by PCR with a 
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pair of primers 5’-GAATTCGAGATCCCGGGACGC-3’ (forward) and 
5’-GTCGACGTCGTCCTTTCATTCCTC-3’ (reverse) using the full-length nephronectin 
cDNA as a template. To express other deletion mutants, a cDNA fragment encoding a 
mouse nephronectin 5’-NTR and signal peptide (from –61 to 69 base pair) was amplified 
by PCR with a pair of primers 5’-GAATTCGAGATCCCGGGACGC-3’ (forward) and 
5’-GGGCCCGTCGAAGTCGGCAGC-3’ (reverse) using full-length nephronectin cDNA 
as a template. This fragment was fused in frame to the cDNAs encoding the EGF-like 
repeat-deleted mutant of nephronectin (abbreviated ΔEGF), the RGD-containing linker 
region (linker), or the MAM domain. The cDNAs encoding the RGD region and the 
MAM domain were amplified by PCR   with pairs of primers 
5’-GGGCCCAAAGTCATGATTGAAC-3’ (forward, named primer A) and 
5’-GTCGACGTCGTCCTTTACTTCCTC-3’ (reverse), and 
5’-GGGCCCGGTATTCTCATACACAGC-3’ (forward) and 
5’-GTCGACGCAGCGACCTCTTTTCAAG-3’ (reverse, named primer B), respectively. 
The cDNA encoding ΔEGF was amplified by PCR with a pair of the primer A (forward) 
and the primer B (reverse) using full-length nephronectin cDNA as a template. After 
verified by DNA sequencing, each PCR-amplified cDNA was subcloned to 
pFLAG-CMV vector in frame to FLAG-tag at 3’ ends. 
  An expression vector for GST fusion protein of the RGD-containing linker segment 
was prepared as follows: A cDNA encoding NN-linker was amplified by PCR with a pair 
of primers 5’-GAATTCCCCAAAGTCATGATTGAACCT-3’ (forward) and 
5’-GTCGACTCAGTCGTCCTTTACTTCCTC-3’ (reverse) using E13.5 mouse embryo 
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cDNA as a template. The PCR product was subcloned into pBlueScriptII SK+ vector 
(Stratagene, La Jolla, CA), digested with EcoRI and SalI and inserted into the 
corresponding restriction sites of the pGEX 4T-1 expression vector (GE Healthcare). An 
expression vector for PRGDV sequence directly conjugated to GST was prepared as 
follows. A pair of primers 5’-TCCCCAGAATTCGGAAGTACAAGCGCCCCCAGAGG 
AGATG-3’ (forward) and 5’- GCGTGTCGACTCAAGTCGCGCTCACATCTCCTCTG 
GGGGC-3’ (reverse) was directly hybridized and amplified by PCR. The PCR product 
was digested with EcoRI and SalI, then inserted into corresponding restriction sites of 
pGEX4T-1 vector.  
  Expression vector for EGF-like repeats of nephronectin with the N-terminal 70 kDa 
domain of human fibronectin  (FN70K), designated FN70K-EGF, was prepared as 
follows: The expression vector pFLAG-FN70K was prepared as described previously 
(Ido et al., 2004). A cDNA encoding the five EGF-like repeats of nephronectin was 
amplified by PCR with a pair of primers 5’-TGAGATCTGACTTCGACGGGAG 
GTGGC-3’ (forward) and 5’-ATCGATATACACACAGTTCAGTCCATCCCC-3’ 
(reverse) using the full-length nephronectin cDNA as a template. After verified by DNA 
sequencing, the PCR-amplified cDNA was subcloned between FN70K and FLAG tag in 
pFLAG-FN70K vector in frame to FN70K at 5’ ends and FLAG-tag at 3’ ends. 
  A cDNA encoding human integrin α8 was amplified by PCR with a pair of primers 
5’-AAGGAAGCTTCCACCATGTCGCCCGGGGCCAGCCGCGG-3’ (forward) and 
5’-AATCACTCGAGTGCCTCAGGGGTCTTGTCATTTG-3’ (reverse) using human 
fetus cDNA (Clontech) as a template. The PCR-amplified cDNA was subcloned to 
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pBlueScript II SK vector and verified by DNA sequencing. An α8 integrin subunit 
expression vector that was truncated before the transmembrane domain and fused to the 
‘ACID’ α-helical coiled-coil peptide with a FLAG-tag was prepared as described 
previously (Nishiuchi et al., 2006; Ido et al., 2007).  Expression vector for a truncated 
soluble β1 integrin subunit with a “BASE” peptide was generously provided by Dr. 
Junichi Takagi (Institute for Protein Research, Osaka University) (Takagi et al., 2001). 
Expression and purification of recombinant proteins—To purify recombinant 
nephronectin, its mutants and soluble α8β1 integrin, FreestyleTM 293-F cells were 
transiently transfected with each plasmid using FreestyleTM 293 Expression system 
(Invitrogen) according to manufacturer’s instructions. The conditioned media were 
collected 48-72 h after transfection, and centrifuged to remove cells and debris. To purify 
nephronectin and its mutants, EDTA (5 mM), PMSF (1 mM), and sodium azide (0.02%) 
were added to the conditioned media. The media were incubated with anti-FLAG M2 
affinity beads (SIGMA), and then the beads were transferred into an empty column and 
washed with PBS. Bound proteins were eluted with 100 µg/ml FLAG peptide dissolved 
in PBS. Purified proteins were dialysed against 2 mM CAPS (N-cyclohexyl-3- 
aminopropanesulfonic acid) buffer (pH 11.4) containing 0.5 mM EDTA and used for the 
following assays. Determination of protein concentration was carried out by 
immunoblotting with anti-FLAG antibody. 
  To purify recombinant soluble α8β1 integrin, PMSF (1 mM) and sodium azide 
(0.02%) were added into the conditioned media. The media were incubated with 
nickel-nitrilotriacetic acid-agarose beads (QIAGEN), followed by washes with 
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Tris-buffered saline (TBS). Bound proteins were eluted with TBS containing 200 mM 
imidazole. The eluted fractions were applied to anti-FLAG M2 affinity beads, and the 
bound proteins were eluted with 100 µg/ml FLAG peptide and dialyzed against TBS. 
Heparin binding assay—Three pmol of nephronectin and its mutants were diluted 
with 1 ml of phosphate buffer (pH 7.4) containing 1 mg/ml bovine serum albumin (BSA), 
0.1% TritonX-100 and the indicated concentrations of NaCl (binding buffer), and then 
incubated with 15 µl of Heparin-Sepharose beads (50% slurry in PBS) for 12 h at 4 oC. 
After centrifugation, the beads were washed three times with 1 ml of binding buffer 
without BSA. Bound proteins were eluted from the beads by being boiled in 30 µl of 
SDS-gel loading buffer containing 6% of β-mercaptoethanol for 5 min. The eluted 
proteins were subjected to SDS-PAGE and visualized by immunoblotting with 
anti-FLAG M2 antibody. As a negative control, the same procedures were carried out 
with Sepharose beads. 
GAG binding assay—The GAG binding assay was performed as described previously 
(Kozaki et al., 2003; Furutani et al., 2005). Briefly, the Maxisorp 96-well plate was 
coated with 20 µg/ml of PE-GAGs. After blocking with PBS containing 1% skim milk, 
plate was incubated with 20 nM of nephronectin and its mutants for 1 h at room 
temperature. The amounts of nephronectin and its mutants bound to the wells not coated 
with PE-GAGs were taken as negative controls, and subtracted as backgrounds. Bound 
proteins were quantified by enzyme-linked immunosorbent assay using anti-FLAG M2 
mAb and HRP-conjugated goat anti-mouse IgG. 
Integrin binding assay—Integrin binding assays were performed as described 
 45 
previously (Nishiuchi et al., 2006). Briefly, microtiter plates were coated with the 
indicated substrates at 10 nM, blocked with 1% BSA, and incubated with integrins in the 
presence of 1 mM MnCl2. The amounts of the integrins bound in the presence of 10 mM 
EDTA were taken as negative controls, and subtracted as backgrounds. The plates were 
washed with TBS containing 1 mM MnCl2, 0.1% BSA, and 0.02% Tween-20 with or 
without 10 mM EDTA, and then the bound integrins were quantified by an 
enzyme-linked immunosorbent assay using the biotinylated rabbit anti-Velcro 
(ACID/BASE coiled-coil) antibody and HRP-conjugated streptavidin. 
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I-4 Results 
 
Purification of Nephronectin and its Deletion Mutants—Nephronectin consists of 
five EGF-like repeats, a linker segment containing the RGD cell-adhesive motif, and a 
MAM domain (Fig. I-1A; Brandenberger et al., 2001; Morimura et al., 2001). To 
elucidate the functions of these regions of nephronectin, I constructed expression vectors 
for full-length nephronectin, the N-terminal region containing five-EGF-like repeats 
(abbreviated NN-EGF), the RGD-linker segment (NN-linker), the C-terminal MAM 
domain (NN-MAM), and deletion mutants lacking the N-terminal five-EGF-like repeats 
(NN-ΔEGF) or the C-terminal MAM domain (NN-ΔMAM). These constructs were fused 
with a FLAG-tag at their C termini to facilitate affinity purification of these recombinant 
proteins (Fig. I-1A, NN-EGF not shown). When these vectors were transfected into 
293-T cells (human embryonic kidney cells stably expressing the large T-antigen of 
SV40), all recombinant proteins except for NN-EGF were expressed and well secreted 
into the conditioned media. NN-EGF was expressed in the 293-T cells, but not secreted 
(data not shown). Although the predicted molecular masses of full-length nephronectin, 
NN-ΔMAM, NN-ΔEGF, NN-RGD, and NN-MAM are 62 kD, 47 kD, 37 kD, 15 kD, and 
18 kD, respectively, molecular masses of the secreted proteins were larger on SDS-PAGE 
under reducing conditions than their predicted sizes (Fig. I-1B). Because the central 
linker segment has a feature of mucin-like region, which contains a lot of serines, 
threonines, and prolines, thus the segment is predicted to be highly O-glycosylated on 
serine and threonine residues (Brandenberger et al., 2001), resulting in the higher 
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molecular masses of the recombinant proteins expressed here.  
 
Fig. I-1. Purification of recombinant nephronectin and its deletion mutants. A, schematic diagrams of 
full-length nephronectin (NN) and its deletion mutants. Closed and open arrowheads indicate the position of 
N-glycosilation sites and the RGD-cell adhesion motifs, respectively. Black squares, signal peptides; gray 
pentagons, EGF-like repeats; open squares, MAM domains; hatched hexagons, FLAG tags. B, purified 
full-length nephronectin and its deletion mutant were subjected to SDS-PAGE on 7-15% gradient gels under 
reducing conditions, followed by CBB staining (left panel) and immunoblotting with anti-FLAG mAb (right 
panel). The positions of molecular size markers are shown on the left of each panel. 
 
Nephronectin Binds to Heparin through the C-terminal MAM Domain—It is well 
known that a lot of ECM proteins possess activities to bind to heparin/heparan sulfate, 
and thus these heparin-binding ECMs are thought to interact with heparan sulfate 
proteoglycans in vivo. The interaction of the ECMs with cell-surface heparan sulfate 
proteoglycans regulates actin re-organization signals together with integrins (Couchman, 
2003). Furthermore, the ECMs also bind to basement membrane-type heparan sulfate 
proteoglycans to regulate spatial distributions of the ECMs (Bezakova and Ruegg, 2003; 
Iozzo, 2005). To examine the activity of nephronectin to bind to heparin, a kind of 
heparan sulfate, I adopted pull-down assays of nephronectin using heparin-Sepharose 
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beads. Nephronectin was precipitated with the heparin-Sepharose beads under 
physiological ionic strength conditions (i.e., 0.135 M NaCl) but not with control 
Sepharose beads (Fig. I-2), indicating that nephronectin possesses an activity to interact 
with heparin in vivo. Since heparin has been shown to interact with proteins through 
electrostatic interaction (Capila and Linhardt, 2002), the interaction of heparin with 
nephronectin was examined in higher ionic strength conditions (0.3 – 0.6 M NaCl). 
Although nephronectin binds to heparin-Sepharose beads even in the presence of 0.3 M 
NaCl, the interactions was not observed in the presence of 0.6 M NaCl, ensuring that 
nephronectin binds to heparin through electrostatic interactions. The interaction was also 
abolished in the presence of 2 mg/ml heparin, confirming the specificity of interaction 
between nephronectin and heparin.  
  To identify the region responsible for the heparin-binding activity of nephronectin, the 
deletion mutants of nephronectin depicted in Fig. I-1A were employed, and their 
heparin-binding activities were assessed (Fig. I-2). Both NN-ΔEGF, a mutant deleted of 
five EGF-like repeats, and NN-MAM, a mutant comprising only the C-terminal MAM 
domain, were capable of binding to heparin. Their binding manners were similar to that 
of full-length nephronectin; the interactions were disrupted in the presence of 0.6 M 
NaCl or 2 mg/ml of heparin. In contrast, both NN-ΔMAM, a mutant deleted of 
C-terminal MAM domain, and NN-linker, a mutant consisting only a central linker 
segment, were not precipitated with heparin-Sepharose even at a physiological NaCl 
concentration. Thus, these results indicate that the MAM domain harbors the activity to 
bind to heparin. 
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Fig. I-2. Heparin-binding activities of full-length nephronectin 
and its deletion mutants. Three pmol of recombinant proteins were 
incubated with Heparin-Sepharose or control Sepharose beads in the 
presence of various concentrations of NaCl or 2 mg/ml of heparin. 
After washing, the beads were boiled with SDS-PAGE sample buffer 
and subjected to SDS-PAGE under reducing conditions. Input lanes 
represent the amount of proteins applied to SDS-PAGE.  
 
 
 
 
 
 
The Binding Activities of Nephronectin to Sulfated GAG Chains—Since heparin is a 
type of the sulfated GAG chains, next I tried to examine the binding activities of 
nephronectin to a series of sulfated GAG chains including heparin. To assess the binding 
activities of nephronectin to GAG chains, I used phosphatidylethanolamine-conjugated 
GAG chains (PE-GAGs), since lipid moieties facilitate absorption of GAGs onto 
hydrophobic plastic surfaces so that the binding activities of nephronectin to GAGs can 
be examined by solid phase assays. Nephronectin was highly active in binding to heparin 
and chondroitin sulfate-E and moderately active in binding to heparan sulfate (Fig. I-3A), 
but only marginal, if any, to other GAGs including chondroitin sulfate-A, -C, -D, 
dermatan sulfate, and hyauronic acid. The binding of nephronectin to heparin, heparan 
sulfate and chondroitin sulfate-E was observed under physiological ionic conditions, 
endorsing its physiological relevance. 
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  To further define the binding domains of nephronectin to GAGs, the deletion mutants of 
nephronectin were also assessed for their activities to bind to PE-GAGs (Fig. I-3A). Both 
NN-ΔEGF and NN-MAM bind strongly to heparin and moderately to heparan sulfate. 
NN-linker had no activities to bind to heparin and heparan sulfate, ensuring the 
prerequisite role of the MAM domain in heparin-binding activity. However, NN-ΔMAM 
also showed moderate binding activity to heparin, even though the binding activities of 
NN-ΔMAM were significantly reduced in comparison with that of full-length nephronectin. 
Since NN-linker showed no activity to bind to heparin, this result suggests that five 
EGF-like repeats has potentials to bind to heparin. The apparent discrepancy in 
heparin-binding activity of the EGF-like repeats between pull-down assays and solid phase 
binding assays may be due to differences in the sensitivities between these assays. In 
contrast to heparin-binding activities, NN-ΔMAM showed potent activity to bind to 
chondroitin sulfate-E, and this binding activity was comparable to that of full-length 
nephronectin. NN-ΔEGF and NN-MAM, on the other hand, exhibited a moderate loss of 
binding activity to chondroitin sulfate-E. Since NN-linker exhibited no binding activity 
toward chondroitin sulfate-E, these results suggest that the EGF-like repeats primarily 
interact with chondroitin sulfate-E, although the MAM domain may have moderate activity 
to bind to chondroitin sulfate-E chain. 
To directly clarify the roles of the EGF-like repeats in chondroitin sulfate-E interaction, 
I tried to purify the EGF-like repeats. As mentioned above, the N-terminal five EGF- like 
repeats of nephronectin was hard to purify since it was not secreted from 293-T cells. To 
overcome this difficulty, the EGF-like repeats were coupled to the N-terminal 70 kDa  
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Fig. I-3. The binding activities of full-length nephronectin 
and its deletion mutants toward PE-conjugated GAG chains. 
A, Ninety-six well plates were coated with 20 µg/ml of 
PE-GAGs and assessed for their activities to bind to 20 nM of 
full-length nephronectin and its deletion mutants, as described 
in “Experimental Procedures”. The results were expressed as 
the means ± S.E. of triplicate determinations. CS, chondroitin 
sulfate; DS, dermatan sulfate; HS, heparan sulfate; HA, 
hyauronic acid; Hep, heparin. B, The 96-well plates were 
coated with CS-E and assessed the binding activities to 4 nM 
(maximal concentration) of five EGF-like repeats conjugated to 
N-terminal 70 kDa domain of fibronectin (FN70K-EGF). The 
results shown were expressed as the means ± S.E. of triplicate 
determinations. 
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domain of fibronectin (FN70K) to facilitate secretion of recombinant proteins in 
mammalian expression systems (Matsuyama et al., 1994; Ido et al., 2004). Thus, purified 
EGF-like repeats conjugated to FN70K (FN70K-EGF) and control FN70K were assessed 
for their capabilities to bind to chondroitin sulfate-E (Fig. I-3B). As expected, FN70K-EGF 
was capable of binding toward chondroitin sulfate-E, while control FN70K exhibited no 
binding activity. These results, taken together, indicate that nephronectin predominantly 
interacts with chondroitin sulfate-E and heparin/heparan sulfate through N-terminal five 
EGF-like repeats and C-terminal MAM domain, respectively. 
 
The Central Linker Segment of Nephronectin Harbors the Activity to Bind to α8β1 
Integrin—Since nephronectin has been shown to serve as a ligand for α8β1 integrin 
(Brandenberger et al., 2001; Morimura et al., 2001), I wondered that the central linker 
segment of nephronectin, which possesses an RGD cell adhesion motif and showed no 
capability to interact with GAG chains, is involved in the interaction with α8β1 integrin. 
To examine this possibility, I purified recombinant α8β1 integrin, in which the 
extracellular domains of the individual α and β subunits were fused to “ACID” and 
“BASE” α-helical coiled-coil peptides, respectively, with an interchain disulfide bond 
(Takagi et al., 2001; Nishiuchi et al., 2006; Fig. I-4A). FLAG and 6xHis tags were fused 
to the C-termini of the ACID and BASE peptides, respectively, to facilitate purification 
of the recombinant integrin. The authenticity of purified α8β1 integrin was confirmed by 
SDS-PAGE and immunoblotting (Fig. I-4B). As expected, the recombinant α8β1 integrin 
gave a single band at ~210 kDa region under non-reducing conditions, confirming that 
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Fig. I-4. Purification of recombinant α8β1 integrin. A, A schematic diagram of a recombinant α8β1 
integrin. B, SDS-PAGE and immunoblot analyses of purified α8β1 integrin. The α8β1 integrin were 
electrophoresed in 12% (for immunoblotting with anti-FLAG mAb under reducing conditions) or 6% (for 
other analyses) SDS-polyacrylamide gels under non-reducing (left panels) or reducing (center and right 
panels) conditions. Proteins were visualized by silver staining (silver) or immunoblotting with antibodies 
specific for the FLAG tag, 5xHis tag, and extracellular domain of α8 integrin (10A8). The positions of 
molecular size markers are shown in the left of each panel. HC, heavy chain; LC, light chain.  
 
the α and β subunits were covalently linked through disulfide bond. After reduction with 
2-mercaptoethanol, the integrin heterodimers were resolved into their individual subunits, 
separated into three bands with the ~130 kDa (α8 heavy chain), ~120 kDa (β1), and ~27 
kDa (α8 light chain). 
  The activity of nephronectin to bind to α8β1 integrin was assessed with the purified 
recombinant α8β1 integrin (Fig. I-5A). To compare the binding capabilities of α8β1 
integrin to other RGD-containing ECM molecules, fibronectin, vitronectin, and 
fibrinogen, were simultaneously assessed for their activities to bind to α8β1 integrin. 
Among the RGD-containing ECM proteins I tested, nephronectin was extremely potent 
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in the binding to α8β1 integrin, although other RGD-containing ECMs including 
fibronectin, vitronectin, and fibrinogen were less active in binding to α8β1 integrin (Fig. 
I-5A). These results indicate that nephronectin harbors the binding site for α8β1 integrin. 
  Since the RGD motif is situated within the linker segment connecting the N-terminal 
EGF-like repeats and the C-terminal MAM domain, I examined whether the 
RGD-containing linker segment could recapitulate the high affinity binding to α8β1 
integrin (Fig. I-5B). Not only full-length nephronectin but also the linker segment bound 
strongly to α8β1 integrin, while the MAM domain of nephronectin had no activity to 
bind to α8β1 integrin, indicating that the linker segment of nephronectin is responsible 
for potent binding to α8β1 integrin. Because the linker segment of nephronectin is 
modified with a lot of O-glycans, I hypothesized that either the O-linked glycans or the 
amino acid sequences within the linker segment are responsible for the potent interaction 
with α8β1 integrin. To this end, I expressed the linker segment as a GST-fusion protein 
in bacteria and assessed its activity to bind to α8β1 integrin. A GST protein with an 
extension of the PRGDV sequence of nephronectin was also prepared and assessed for its 
binding to α8β1. The GST fusion protein of the linker segment was also capable of 
potent binding to α8β1 integrin (Fig. I-5B), thus indicating that the O-glycans have 
nothing to do with the interaction with α8β1 integrin. On the other hand, the GST protein 
containing the PRGDV sequence of nephronectin was significantly less potent in the 
binding to α8β1 integrin, suggesting that the amino acid sequence within the linker 
segment, besides the RGD motif, is required for strong binding of nephronectin to α8β1 
integrin. These results, taken together, strongly suggest that the central linker segment of 
 55 
nephronectin harbors the α8β1 integrin binding capability of nephronectin. 
 
Fig. I-5. The binding activities of the α8β1 integrin to RGD-containing ECM proteins and the 
central linker segment of nephronectin. Ninety-six well microtiter plates were coated with 10 nM of 
RGD-containing ECM proteins (A) or deletion mutants of nephronectin (B) indicated at the bottom of each 
panel, and then incubated with 10 nM of α8β1 integrin in the presence of 1 mM Mn2+. The bound 
integrins were quantified as described in “Experimental Procedures”. The amounts of the integrins bound 
in the presence of 10 mM EDTA were taken as negative controls, and subtracted as backgrounds. The 
results are expressed as the means ± S.E. of triplicate determinations. NN, nephronectin; FN, fibronectin; 
VN, vitronectin; Fbg, fibrinogen  
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I-5 Discussion 
 
  In the previous studies, nephronectin has been analyzed in its expression/distribution 
patterns and cell adhesive/integrin-binding activities (Brandenberger et al., 2001; 
Morimura et al., 2001). However, the analyses of nephronectin were carried out mainly 
using the bacterially expressed proteins from which the N-terminal five EGF-like repeats 
were deleted. Here, I purified full-length nephronectin, for the first time, and its deletion 
mutants using mammary expression systems, and then I investigated the functions of the 
individual domains of nephronectin with respect to their capabilities to bind to GAG 
chains and α8β1 integrin. My results indicated that nephronectin interacts with 
chondroitin sulfate-E and heparin/heparan sulfate chains through its N-terminal EGF-like 
repeats and C-terminal MAM domain, respectively, whereas the central linker segment 
containing the RGD motif is responsible for exerting high-affinity interaction of 
nephronectin with α8β1 integrin. Therefore, these results suggest that nephronectin binds 
to chondroitin sulfate and heparan sulfate proteoglycans through its N-terminal and 
C-terminal domains, respectively, and to α8β1 integrin through its central linker segment 
(Fig. I-6). Previously, Morimura et.al. reported that deletion of the MAM domain of 
nephronectin resulted in reduced tendency of nephronectin to localize at cell surface, 
while substitution of RGE for the RGD motif, which reduces the activity of nephronectin 
to bind to integrins, did not affect the localization of nephronectin at the cell surface 
(Morimura et al., 2001). This observation indicates that nephronectin interacts with cells 
through the MAM domain, thus supporting the idea that the MAM domain of 
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Fig. I-6. A schematic model of domain functions of nephronectin in vivo. Nephronectin (NN) interacts 
with chondroitin sulfate and heparan sulfate proteoglycans, localized at cell surface or ECMs, through its 
N-terminal five EGF-like repeats and C-terminal MAM domain, respectively. The central linker segment 
containing the RGD motif harbors potent activity to bind to α8β1 integrin. Since the chondroitin 
sulfate/heparan sulfate proteoglycans are abundantly expressed in ECMs and cell surfaces in developing 
kidney, it is plausible that NN bind to ECM-type proteoglycans to deposit onto ECMs/basement membranes, 
and/or to cell-surface proteoglycans to transmit appropriate signals into cells collaborating with α8β1 
integrin. Blue spheres, chondroitin sulfates; pink spheres, heparan sulfates.  
 
nephronectin interacts with cell surface heparan sulfate proteoglycans. 
  Nephronectin is primarily composed of three functional domains, that is, N-terminal 
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five EGF-like repeats, central linker segment containing an RGD cell adhesion motif, 
and C-terminal MAM domain. Among these, the MAM domain, consisting of ~170 
amino acid residues with characteristic hydrophobic and four cysteine residues, is found 
in several transmembrane and ECM proteins (Beckmann and Bork, 1993). MAM 
domains have been shown to mediate protein-protein interactions, especially in 
homophilic/heterophilic interactions. Thus, meprins, transmembrane metalloproteases 
possessing a MAM domain, have been shown to form meprin oligomers through 
homophilic interaction between MAM domains (Ishmael et al., 2001; Ishmael et al., 
2005). Neuropilin-1 and -2 have also been shown to form homo- and hetero-oligomers 
through an interaction involving the MAM domain (Chen et al., 1998). Moreover, the 
MAM domain of receptor protein tyrosine phosphatase µ has been shown to contribute to 
cell-cell adhesion through homophilic interaction between the MAM domains 
(Brady-Kalnay et al., 1993; Zondag et al., 1995; Cismasiu et al., 2004). Relevant to these 
observations, the purified MAM domain of nephronectin seems to form a dimer, since 
the purified MAM domain gave two bands with ~20 and ~40 kDa, possibly the MAM 
domain monomer and dimer, respectively, on SDS-PAGE (Fig. I-1B; page 48). Therefore, 
nephronectin may also interact each other to form homo-oligomers through its MAM 
domain. 
The MAM domain of nephronectin differs from other MAM domains in the isoelectric 
points. The calculated isoelectric points of the MAM domains except for nephronectin 
are between 4.3 and 6.7, indicating that most of the MAM domains are negatively 
charged at the physiological pH (Table I-1). The MAM domain of nephronectin, however, 
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has an isoelectric point of 10.5, indicating that the MAM domain of nephronectin 
possesses much more basic residues than the other MAM domains (Table I-1). The 
property of the MAM domain of nephronectin, i.e., abundance in positive charges, may 
cause the interaction with highly sulfated GAG chains, including heparin/heparan sulfate 
and chondroitin sulfate-E, which are abundant in negative charges. 
 
Table I-1. 
Calculated isoelectric points (pI) of the MAM domains 
 
 
 
a, all protein sequences are derived from mice 
b, pI calculations were performed by EMBL WWW 
  Gateway to Isoelectric Point Service 
  (http://www.embl-heidelberg.de/cgi/pi-wrapper.pl) 
c, RPTP, Receptor Protein Tyrosine Phosphatase 
 
 
   
 
  Although nephronectin binds to heparin/heparan sulfate through the MAM domain, the 
physiological roles of the interaction of nephronectin with heparin/heparan sulfate are 
still unclear. One possible role could be that the interaction with heparan sulfate 
proteoglycans enables nephronectin to be deposited onto the basement membranes (Fig. 
I-6). It should be noted that most of ECM-type heparan sulfate proteoglycans are 
localized at the basement membranes. For example, perlecan is a constitutive basement 
membrane protein present in all mature basement membranes (Timpl and Brown, 1996). 
a Proteins b Calculated pI 
Nephronectin 10.5 
Meprin-a 5.9 
Meprin-b 5.2 
Neuropilin-1 6.7 
Neuropilin-2 4.9 
c RPTPµ 5.1 
RPTPκ 4.3 
MAEG 4.9 
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Agrin is also found ubiquitously in basement membranes (Manabe et al., 2008). Type 
XVIII collagen is located at most of the basement membranes in various organs and 
blood vessels (Miosge et al., 2003). Indeed, it has been reported that nephronectin is 
localized at basement membranes of various organs including developing kidney 
(Brandenberger et al., 2001). Thus, nephronectin may determine its localization at the 
basement membranes through the interaction of its MAM domain with the heparan 
sulfate proteoglycans. 
The interaction of nephronectin with basement membrane-type heparan sulfate 
proteoglycans may also contribute to spatiotemporal distributions of multiple soluble 
factors. So far, multiple soluble factors, including GDNF, Wnt, BMPs and FGFs, have 
been shown to interact with heparan sulfate proteoglycans through their GAG chains 
(Kispert et al., 1996; Allen et al., 2001; Clayton et al., 2001; Grisaru et al., 2001; Qiao et 
al., 2001; Barnett et al., 2002). This interaction are thought to be involved in generating a 
concentration gradient of the soluble factors (Lander, 1999). As mentioned above, most 
of ECM-type heparan sulfate proteoglycans are located at the basement membranes, thus 
most of soluble factors expressed by cells should be sequestered by basement membranes. 
Since nephronectin is also located at the basement membranes and has potentials to bind 
to heparan sulfate proteoglycans, the interaction of nephronectin with heparan sulfates 
may dissociate and/or insulate the soluble factors from heparan sulfates, thereby allowing 
the factors to be diffused in connective tissues and mesenchymes. 
Another possible explanation for the roles of heparin binding activities of nephronectin 
could be to regulate physiological functions of nephronectin, such as signal transduction 
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through α8β1 integrin. Heparan sulfates have been shown to regulate physiological 
functions and activities of proteins possessing heparin-binding properties. For example, 
the interaction between FGF and FGFR necessitates heparan sulfate to enhance the 
stability of FGF-FGFR complex by cross-linking ligand and receptor (Pellegrini et al., 
2000; Schlessinger et al., 2000). With respect to ECM proteins, it has been shown that 
both the heparin- and α5β1 integrin-binding domains of fibronectin are required for 
stress fiber formation of the cells adhering to fibronectin. In this case, the heparin- 
binding domain of fibronectin probably interacts with the heparan sulfate chains of 
syndecan-4 on cell surface (Yoneda et al., 1995; Bloom et al., 1999; Saoncella et al., 
1999). Similarly, both heparin- and α5β1 integrin-binding domains of fibrillin-1 are 
required for stress fiber formation of the cells adhering to fibrillin-1 (Bax et al., 2007). 
Since nephronectin is one of the ECM proteins possessing integrin- and heparin-binding 
activities, these observations give rise to a possibility that nephronectin may interact with 
both α8β1 integrin and cell surface heparan sulfate proteoglycans, cooperatively 
transmitting signals to exert various effects such as reorganization of actin cytoskeletons. 
  α8β1 integrin, identified as an RGD-recognizing integrin, has been shown to serve as a 
receptor for various RGD motif-containing ECM ligands including fibronectin, 
vitronectin, nephronectin, and osteopontin (Schnapp et al., 1995; Denda et al., 1998b; 
Brandenberger et al., 2001; Morimura et al., 2001). In my experiments, however, 
recombinant α8β1 integrin selectively bound to nephronectin, suggesting that 
nephronectin is a preferential ligand for α8β1 integrin. One might argue that the selective 
recognition of nephronectin by α8β1 integrin may be an artifact due to the deletion of the 
 62 
transmembrane/cytoplasmic domain and forced dimerization of integrins. However, the 
feasibility of this strategy for the expression of recombinant integrins has previously 
been demonstrated for many integrins including α3β1, α4β1, α5β1, α6β1, and αVβ3 (Lu 
et al., 2001; Takagi et al., 2001; 2002a; 2002b; Nishiuchi et al., 2006). The activities of 
recombinant integrins have been shown to principally recapitulate that of endogeneously 
expressed integrins on the cell surface or that of purified integrins from tissue extracts. 
Therefore, the specific interaction of recombinant α8β1 integrin with nephronectin 
should also reflect the activity of α8β1 integrin in vivo. 
  The central linker segment of nephronectin can replicate the high-affinity binding 
activity of nephronectin to α8β1 integrin, irrespective of the cells used for expression of 
the linker segment, i.e., bacterial or mammary cells. However, PRGDV peptide fused 
with GST at the C-terminus had only marginal, if any, activity to bind to α8β1 integrin. 
Since the GST-fusion protein of linker segment is expressed without modification of 
O-linked sugar chains, these results strongly suggest that the linker segment of 
nephronectin possesses particular amino acid sequences specifically recognized by α8β1 
integrin. This situation quite resembles that of interaction of fibronectin with α5β1 
integrin. Although α5β1 integrin binds to fibronectin in an RGD-dependent manner, the 
RGD motif itself is significantly less active in binding to α5β1 integrin than intact 
fibronectin. α5β1 integrin has been shown to recognize not only the RGD motif but also 
synergistic binding site in the vicinity of the RGD motif (Aota et al., 1994; Redick et al., 
2000). Therefore, these observations raise a possibility that α8β1 integrin may recognize 
not only the RGD motif but also the non-RGD residues within the central linker segment. 
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In Chapter II, I describe the results of my investigation of this hypothesis. 
  In the present study, I investigated the domain functions of nephronectin, i.e., the 
functions of N-terminal five EGF-like repeats, the central linker segment containing an 
RGD motif, and C-terminal MAM domain. I found that nephronectin binds to 
chondroitin sulfate-E and heparin/heparan sulfate through its N-terminal EGF-like 
repeats and C-terminal MAM domain, respectively. Furthermore, I found that the central 
linker segment of nephronectin is a region selectively recognized by α8β1 integrin. 
These results suggest that nephronectin interacts with proteoglycans as well as α8β1 
integrin. Thus, nephronectin may play crucial roles in kidney morphogenesis, providing a 
“bridge” between the functions of α8β1 integrin and GAG chains including heparan 
sulfate and chondroitin sulfate. I hope that my observations in this research provide new 
insights into the functions of integrins and proteoglycans in kidney morphogenesis. 
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Chapter II 
 
 
Molecular Basis of the Recognition of  
Nephronectin by Integrin α8β1 
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II-1 Summery 
 
Integrin α8β1 interacts with a variety of Arg-Gly-Asp (RGD)-containing ligands in the 
ECM. Here, I examined the binding activities of α8β1 integrin toward a panel of 
RGD-containing ligands. Integrin α8β1 bound specifically to nephronectin with an 
apparent dissociation constant of 0.28±0.01 nM, but showed only marginal affinities for 
fibronectin and other RGD-containing ligands. The high-affinity binding to α8β1 
integrin was fully reproduced with a recombinant nephronectin fragment derived from 
the RGD-containing central linker segment. A series of deletion mutants of the 
recombinant fragment identified the LFEIFEIER sequence on the C-terminal side of the 
RGD motif as an auxiliary site required for high-affinity binding to α8β1 integrin. 
Alanine scanning mutagenesis within the LFEIFEIER sequence defined the EIE 
sequence as a critical motif ensuring the high-affinity integrin-ligand interaction. 
Although a synthetic LFEIFEIER peptide failed to inhibit the binding of α8β1 integrin to 
nephronectin, a longer peptide containing both the RGD motif and the LFEIFEIER 
sequence was strongly inhibitory, and was ~2,000-fold more potent than a peptide 
containing only the RGD motif. Furthermore, trans-complementation assays using 
recombinant fragments containing either the RGD motif or LFEIFEIER sequence 
revealed a clear synergism in the binding to α8β1 integrin. Taken together, these results 
indicate that the specific high-affinity binding of nephronectin to α8β1 integrin is 
achieved by bipartite interaction of the integrin with the RGD motif and LFEIFEIER 
sequence, with the latter serving as a synergy site that greatly potentiates the RGD-driven 
 66 
integrin-ligand interaction but has only marginal activity to secure the interaction by 
itself. 
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II-2 Introductions 
 
Integrins are a family of adhesion receptors that interact with a variety of 
extracellular ligands, typically cell-adhesive proteins in the ECM. They play mandatory 
roles in embryonic development and the maintenance of tissue architectures by providing 
essential links between cells and the ECM (Hynes, 1992). Integrins are composed of two 
non-covalently associated subunits, termed α and β. In mammals, 18 α and 8 β subunits 
have been identified, and combinations of these subunits give rise to at least 24 distinct 
integrin heterodimers. Based on their ligand-binding specificities, ECM-binding integrins 
are classified into three groups, namely laminin-, collagen- and RGD-binding integrins 
(Hynes, 2002; Takagi, 2007), of which the RGD-binding integrins have been most 
extensively investigated. The RGD-binding integrins include α5β1, α8β1, αIIbβ3 and 
αV-containing integrins, and have been shown to interact with a variety of ECM ligands, 
such as fibronectin and vitronectin, with distinct binding specificities. 
The α8 integrin subunit was originally identified in chick nerves (Bossy et al., 1991). 
Integrin α8β1 is expressed in the metanephric mesenchyme and plays a crucial role in 
epithelial-mesenchymal interactions during the early stages of kidney morphogenesis. 
Disruption of the α8 gene in mice was found to be associated with severe defects in 
kidney morphogenesis (Muller et al., 1997) and stereocilia development (Littlewood 
Evans and Muller, 2000). To date, α8β1 integrin has been shown to bind to fibronectin, 
vitronectin, osteopontin, latency-associated peptide of transforming growth factor 
(TGF)-β1, tenascin-W and nephronectin (Muller et al., 1995; Schnapp et al., 1995; 
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Denda et al., 1998b; Brandenberger et al., 2001; Morimura et al., 2001; Lu et al., 2002; 
Scherberich et al., 2004), among which nephronectin is believed to be an α8β1 integrin 
ligand involved in kidney development (Brandenberger et al., 2001). 
Nephronectin is one of the basement membrane proteins whose expression and 
localization patterns are restricted in a tissue-specific and developmentally regulated 
manner (Brandenberger et al., 2001; Morimura et al., 2001). Nephronectin consists of 
five EGF-like repeats, a linker segment containing the RGD cell-adhesive motif 
(designated RGD-linker) and a MAM domain. Although the physiological functions of 
nephronectin remain only poorly understood, it is thought to play a role in 
epithelial-mesenchymal interactions through binding to α8β1 integrin, thereby 
transmitting signals from the epithelium to the mesenchyme across the basement 
membrane (Brandenberger et al., 2001). Recently, mice deficient in nephronectin 
expression were produced by homologous recombination (Linton et al., 2007). The 
nephronectin-deficient mice frequently displayed kidney agenesis, a phenotype 
reminiscent of α8 integrin-knockout mice (Linton et al., 2007), despite the fact that other 
RGD-containing ligands, including fibronectin and osteopontin, were expressed in the 
embryonic kidneys (Ekblom, 1981; Denda et al., 1998b). The failure of the other 
RGD-containing ligands to compensate for the deficiency of nephronectin in the 
developing kidneys suggests that nephronectin is an indispensable α8β1 ligand that plays 
a mandatory role in epithelial-mesenchymal interactions during kidney development. 
Although ligand recognition by RGD-binding integrins is primarily determined by 
the RGD motif in the ligands, it is the residues outside the RGD motif that define the 
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binding specificities and affinities toward individual integrins (Ruoslahti, 1996; Takagi, 
2004). For example, α5β1 integrin specifically binds to fibronectin among the many 
RGD-containing ligands, and requires not only the RGD motif in the tenth type III repeat 
but also the so-called ‘synergy site’ within the preceding ninth type III repeat for 
fibronectin recognition (Aota et al., 1994). Recently, DiCara et al. (DiCara et al., 2007) 
demonstrated that the high-affinity binding of αVβ6 integrin to its natural ligands, e.g., 
foot-and-mouth disease virus, requires the RGD motif immediately followed by a 
Leu-Xaa-Xaa-Leu/Ile sequence, which forms a helix to align the two conserved 
hydrophobic residues along the length of the helix. Given the presence of many naturally 
occurring RGD-containing ligands, it is conceivable that the specificities of the 
RGD-binding integrins are dictated by the sequences flanking the RGD motif or those in 
neighboring domains that come into close proximity with the RGD motif in the intact 
ligand proteins. However, the preferences of α8β1 integrin for RGD-containing ligands 
and how it secures its high-affinity binding toward its preferred ligands remain unknown.  
In the present study, I investigated the binding specificities of α8β1 integrin toward 
deletion mutants of the linker segment of nephronectin. My data reveal that a 
LFEIFEIER sequence on the C-terminal side of its RGD motif serves as a synergy site to 
ensure the specific high-affinity binding of nephronectin to α8β1 integrin. 
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II-3 Materials and Methods 
 
Cells and Reagents—HT1080 cells were maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% fetal bovine serum. HT1080 cells were 
transfected with an expression vector for human full-length α8 integrin (described 
below). The cells were passaged at 24 h after transfection and maintained in medium 
containing 0.8 mg/ml G418 to select stable transfectants. The transfectants were 
subjected to selection by cell adhesion to a nephronectin-coated substratum as follows. 
The cells were seeded onto 6-well plates (Falcon) that had been coated with 10 nM 
nephronectin and blocked with phosphate-buffered saline (PBS) containing 10 mg/ml of 
BSA, and allowed to adhere for 30 min at 37°C. After removal of non-adherent cells 
using serum-free medium, the remaining cells were detached with PBS containing 
0.025% trypsin and 1 mM EDTA, plated on 6-well plates and grown to confluence. The 
resulting cells (designated HT1080-A8 cells) were cloned by limiting dilution and used 
for cell adhesion assays. K562 human erythroleukemic cells stably transfected with a 
chicken α8 integrin cDNA (KA8 cells) were kindly provided by Dr. Louis F. Reichardt 
(University of California, San Francisco, CA) and maintained as described previously 
(Muller et al., 1995).  
Human plasma fibronectin and vitronectin were purified from outdated human 
plasma by gelatin- and heparin-affinity chromatography, respectively, as described 
previously (Sekiguchi et al., 1983; Yatohgo et al., 1988). Human fibrinogen was 
purchased from Enzyme Research Laboratories Inc. (South Bend, IN). A polyclonal 
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antibody against actin and a horseradish peroxidase (HRP)-conjugated monoclonal 
antibody (mAb) against FLAG tag were obtained from Sigma (St. Louis, MO). An 
HRP-conjugated polyclonal antibody against glutathione S-transferase (GST) was 
purchased from GE Healthcare (Piscataway, NJ). HRP-conjugated peanut agglutinin 
(PNA) was purchased from Seikagaku Co. (Tokyo, Japan). mAbs against the human 
integrin α8 subunit were produced by fusion of Sp2 mouse myeloma cells with spleen 
cells from mice immunized with recombinant soluble integrin α8β1, and selected by both 
positive reactivity for recombinant integrin α8β1 and negative reactivity for recombinant 
integrin α5β1. mAb 10A8 was capable of binding to the denatured integrin α8 chain on 
immunoblots under reducing and non-reducing conditions. mAb 7A5 was capable of 
binding to the non-denatured integrin α8 chain, and was used for flow cytometry. 
Synthetic peptides were purchased from Biologica Co. (Nagoya, Japan) and dissolved 
into 100% dimethyl sulfoxide (DMSO). 
Expression Vectors—A mouse nephronectin cDNA was obtained from Dr. Yoshihide 
Hayashizaki (Riken, Yokohama, Japan). The cDNA was subcloned into the pFLAG-CMV 
vector (Invitrogen, Carlsbad, CA) in-frame with a FLAG tag at the 3’ end. For expression 
of a panel of nephronectin deletion mutants in mammalian cells, a cDNA fragment 
encoding a mouse nephronectin 5’-non-translated region and the signal peptide 
(nucleotides –61 to 69) was amplified by PCR with the primer set 
5’-GAATTCGAGATCCCGGGACGC-3’ (forward) and 
5’-GGGCCCGTCGAAGTCGGCAGC-3’ (reverse) using the full-length nephronectin 
cDNA as a template. This fragment was digested with EcoRI and ApaI, and fused 
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in-frame with cDNAs encoding the RGD-linker segment or the MAM domain. The 
cDNAs encoding the RGD-linker and the MAM domain were amplified by PCR with the 
primer sets 5’-GGGCCCAAAGTCATGATTGAAC-3’ (forward) and 
5’-GTCGACGTCGTCCTTTACTTCCTC-3’ (reverse), and 
5’-GGGCCCGGTATTCTCATACACAGC-3’ (forward) and 
5’-GTCGACGCAGCGACCTCTTTTCAAG-3’ (reverse), respectively. After verification 
by DNA sequencing, each PCR-amplified cDNA was digested with ApaI and SalI, and 
inserted into the EcoRI and SalI sites of the pFLAG-CMV vector together with the cDNA 
encoding the 5’-non-translated region and signal peptide. 
An expression vector for the RGD-linker as a GST fusion protein was prepared as 
follows. A cDNA encoding the RGD-linker was amplified by PCR with the primer set 
5’-GAATTCCCCAAAGTCATGATTGAACCT-3’ (forward) and 
5’-GTCGACTCAGTCGTCCTTTACTTCCTC-3’ (reverse) using an E13.5 mouse 
embryo cDNA as a template. The PCR product was subcloned into the pBlueScriptII 
SK+ vector (Stratagene, La Jolla, CA), digested with EcoRI and SalI and inserted into 
the corresponding restriction sites of the pGEX 4T-1 expression vector (GE Healthcare) 
(designated pGEX-RGD-linker). cDNAs encoding a series of deletion mutants and 
substitution mutants of the RGD-linker region were amplified by PCR using 
pGEX-RGD-linker encoding the GST-RGD-linker fusion protein as a template. A list of 
the primer sequences used for PCR is available upon request. The PCR products were 
digested with EcoRI and SalI and inserted into the corresponding restriction sites of 
pGEX 4T-1. 
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A cDNA encoding the human integrin α8 subunit was amplified by PCR with the 
primer set 5’-AAGGAAGCTTCCACCATGTCGCCCGGGGCCAGCCGCGG-3’ 
(forward) and 5’-AATCACTCGAGTGCCTCAGGGGTCTTGTCATTTG-3’ (reverse) 
using a human fetal cDNA (Clontech, Palo Alto, CA) as a template. The PCR-amplified 
cDNA was subcloned into pBlueScript II SK+ and verified by DNA sequencing. A cDNA 
encoding the intact α8 integrin subunit was prepared by addition of a stop codon and 
insertion into the pcDNA 3.1 vector (Invitrogen). An expression vector for an integrin α8 
subunit that was truncated before the transmembrane domain and fused to the ‘ACID’ 
α-helical coiled-coil peptide with a FLAG tag was prepared as described previously 
(Nishiuchi et al., 2006; Ido et al., 2007). Expression vectors for recombinant soluble αV, 
β1 and β3 integrin subunits were previously described (Takagi et al., 2001; Takagi et al., 
2002b). 
Expression and Purification of Recombinant Proteins—For purification of 
recombinant nephronectin, its mutants and integrins, Freestyle™ 293-F cells were 
transiently transfected with individual plasmids using a Freestyle™ 293 Expression 
system (Invitrogen) according to the manufacturer’s instructions. Conditioned media 
were collected at 48-72 h after transfection and centrifuged to remove cells and debris. 
For purification of nephronectin and its mutants, EDTA (5 mM), phenylmethylsulfonyl 
fluoride (PMSF; 1 mM) and sodium azide (0.02%) were added to the conditioned media. 
The media were then incubated with anti-FLAG M2 affinity beads (Sigma) overnight 
with gentle agitation at 4°C. The beads were transferred into an empty column and 
washed with PBS. Bound proteins were eluted with 100 µg/ml FLAG peptide dissolved 
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in PBS. The purified proteins were dialyzed against 2 mM CAPS 
(N-cyclohexyl-3-aminopropane sulfonic acid) buffer (pH 11.4) containing 0.5 mM EDTA, 
and used in the following assays. For purification of recombinant integrins, PMSF (1 
mM) and sodium azide (0.02%) were added to the conditioned media. The media were 
then incubated with nickel-nitrilotriacetic acid-agarose beads (Qiagen, Valencia, CA), 
followed by washing with Tris-buffered saline (TBS). Bound proteins were eluted with 
TBS containing 200 mM imidazole. The eluted proteins were applied to anti-FLAG M2 
affinity beads, and the bound proteins were eluted with 100 µg/ml FLAG peptide and 
dialyzed against TBS. 
GST fusion proteins were induced in Escherichia coli by overnight incubation with 
0.1 mM isopropyl-β-D-thiogalactopyranoside at 25°C. The cells were then lysed by 
sonication, and the supernatants were passed over a glutathione Sepharose 4B column 
(GE Healthcare). Bound proteins were eluted with 50 mM Tris-HCl (pH 8.0) containing 
10 mM glutathione, and then dialyzed against 2 mM CAPS buffer containing 0.5 mM 
EDTA. Protein concentrations were determined by the Bradford method, except for those 
of the nephronectin deletion mutants expressed in 293-F cells, which were determined by 
immunoblotting with an anti-FLAG antibody owing to the very low reactivity of the 
highly glycosylated RGD-linker with the Bradford reagent.  
SDS-PAGE and Western Blotting—SDS-PAGE was carried out according to Laemmli 
(Laemmli, 1970) using 8%, 12% or 7-15% gradient gels. Separated proteins were 
visualized by Coomassie Brilliant Blue (CBB) staining or transferred onto polyvinylidene 
difluoride (for immunoblotting) or nitrocellulose (for lectin blotting) membranes. The 
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membranes were probed with antibodies (for immunoblotting) or PNA (for lectin blotting), 
followed by visualization with an ECL detection kit (GE Healthcare).  
Gel Filtration—Purified nephronectin (500 µl) was loaded on a Superose 6 gel 
filtration column (10 x 300 mm; GE Healthcare) equilibrated in PBS. Fractions were 
collected at a flow rate of 0.2 ml/min and monitored for their absorbance at 280 nm. The 
column was calibrated with the following molecular mass standards: chymotrypsinogen, 
25 kDa; ovalbumin, 43 kDa; catalase, 232 kDa; ferritin, 440 kDa; thyroglobulin, 669 
kDa. 
Integrin Binding Assay—Integrin binding assays were performed as described 
previously (Nishiuchi et al., 2006). Briefly, microtiter plates were coated with various 
substrate proteins (10 nM) overnight at 4°C, and then blocked with 10 mg/ml BSA. In 
trans-complementation assays, the plates were coated with the first substrate protein, 
washed with PBS, coated with the second substrate proteins overnight at 4°C and then 
blocked with BSA. The plates were incubated with integrins in the presence of 1 mM 
MnCl2 with or without 10 mM EDTA. In some experiments, integrins were incubated on 
the plates in the presence of 1 mM CaCl2 and 1 mM MgCl2 to see the effects of divalent 
cations or in the presence of synthetic peptides at various concentrations to evaluate their 
inhibitory activities. The plates were washed with TBS containing 1 mM MnCl2, 0.1% 
BSA and 0.02% Tween-20 with or without 10 mM EDTA, followed by quantification of 
bound integrins by an enzyme-linked immunosorbent assay using a biotinylated rabbit 
anti-Velcro (ACID/BASE coiled-coil) antibody and HRP-conjugated streptavidin. 
Dissociation constants were calculated by saturation binding assays as described 
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previously (Nishiuchi et al., 2003). 
Flow Cytometry—Flow cytometric analyses were performed as described previously 
(Gu et al., 2001). Suspended cells were incubated with anti-integrin mAbs for 30 min at 
4°C. After washing with PBS, the cells were incubated with an Alexa Fluor® 488-labeled 
secondary antibody (Molecular Probes, Eugene, OR) for 30 min at 4°C and subjected to 
flow cytometric analysis using a FACScan flow cytometer (Becton Dickinson, San Jose, 
CA). 
Cell Adhesion Assays—Microtiter plates were coated overnight at 4°C with substrate 
proteins diluted to various concentrations in PBS in a volume of 50 µl/well. The coating 
efficiencies of GST fusion proteins were determined by their reactivities with an 
anti-GST polyclonal antibody. The plates were blocked with blocking medium 
(serum-free DMEM containing 10 mg/ml BSA and 10 mM HEPES, pH 7.5) for 1 h at 
37°C. HT1080-A8 cells resuspended in blocking medium were plated at 4.0 × 104 
cells/well and incubated for 30 min at 37°C in a humidified atmosphere of 5% CO2 in air. 
For cell adhesion inhibition assays, cells were preincubated with synthetic peptides in 
blocking medium at room temperature for 10 min prior to plating. After removal of 
non-adherent cells by washing with blocking medium, the attached cells were fixed with 
3.7% formaldehyde, washed three times with PBS and stained for 10 min with 0.1% 
toluidine blue in PBS. After lysis in 1% SDS, the attached cells were quantified by their 
absorption at 595 nm. 
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II-4 Results 
 
α8β1 Integrin Preferentially Binds to Nephronectin—To examine the binding 
specificities of α8β1 integrin toward nephronectin and other RGD-containing ECM 
ligands, we expressed and purified recombinant nephronectin using a mammalian 
expression system. A FLAG tag was added to the C-terminus of nephronectin to facilitate 
affinity purification of the recombinant protein. The authenticity of the purified 
nephronectin was verified by SDS-PAGE and immunoblotting against the FLAG tag (Fig. 
II-1A). Purified nephronectin gave a broad band at ~120 kDa under reducing conditions, 
which was significantly larger than the predicted protein size (61 kDa). The apparent 
discrepancy was probably caused by modification with a large number of O-linked sugar 
chains, which has been predicted to occur at the mucin-like region within the central 
linker segment (Brandenberger et al., 2001; Morimura et al., 2001). The recombinant 
nephronectin gave a less prominent band at ~120 kDa upon immunoblotting with an 
anti-FLAG mAb under non-reducing conditions (Fig. II-1A), possibly due to the 
occurrence of disulfide-bonded multimers that did not enter the resolving gel. Multimer 
formation by nephronectin was further confirmed by gel filtration chromatography using 
a Superose 6 column. Nephronectin eluted at a position slightly after the void volume 
(Fig. II-1B). The second major peak that eluted at 21 ml was identified by N-terminal 
amino acid sequencing as the FLAG peptide used for elution of recombinant 
nephronectin from the immunoaffinity column (data not shown). Multimer formation by 
recombinant nephronectin was further confirmed by native PAGE (data not shown). 
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Fig. II-1. Expression and purification of recombinant nephronectin. A, 0.5 µg (for CBB staining) or 
0.1 µg (for immunoblotting with a mAb against FLAG tag) of purified nephronectin was subjected to 
SDS-PAGE in 8% gels under reducing (left) and non-reducing (right) conditions. The positions of 
molecular size markers are shown in the left margin. The arrow points to the interface between the 
stacking and resolving gels. B, 500 µl of purified nephronectin was applied to a Superose 6 column 
immediately after elution from an anti-FLAG affinity column. Fractions were collected at 1 ml/tube and 
monitored for their absorbance at 280 nm. The elution positions of molecular size markers are indicated by 
arrows. The asterisk points to the peak arising from the FLAG peptide used for elution of nephronectin 
from the anti-FLAG affinity column. 
 
Purified recombinant nephronectin was subjected to integrin binding assays along 
with other RGD-containing proteins including fibronectin, vitronectin and fibrinogen. 
The assays were performed in the presence of 1 mM Mn2+ to fully activate integrins. 
Although α8β1 integrin was previously reported to bind to fibronectin and vitronectin 
(Muller et al., 1995; Schnapp et al., 1995), the binding activity of α8β1 integrin toward 
nephronectin far exceeded those toward fibronectin, vitronectin and fibrinogen (Fig. 
II-2A). Saturation binding assays revealed that α8β1 integrin bound to nephronectin with 
a dissociation constant of 0.28 ± 0.01 nM, which was approximately two orders of 
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Fig. II-2. Binding activities of integrins toward nephronectin 
and other RGD-containing proteins. A, 96-well microtiter 
plates were coated with various RGD-containing proteins (10 
nM) and then incubated with α8β1 integrin (10 nM) in the 
presence of 1 mM Mn2+. FN, fibronectin; VN, vitronectin; Fbg, 
fibrinogen; NN, nephronectin. Bound integrins were quantified 
as described in the Experimental Procedures. The amounts of 
integrin bound in the presence of 10 mM EDTA were taken as 
negative controls, and subtracted as backgrounds. The results 
represent the means of duplicate determinations. B, titration 
curves of recombinant α8β1 integrin bound to fibronectin 
(diamonds), vitronectin (squares), fibrinogen (triangles) and 
nephronectin (circles). Microtiter plates coated with individual proteins (10 nM) were incubated with 
increasing concentrations of α8β1 in the presence of 1 mM Mn2+, followed by quantification of the bound 
integrins in the Experimental Procedures. The results represent the means of duplicate determinations. C-E, 
microtiter plates were coated with substrates as in A, and incubated with 10 nM of α5β1 (C), αIIbβ3 (D), 
and αVβ3 (E) integrins. Bound integrins were quantified as described in the Experimental Procedures. 
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magnitude lower than that for fibronectin (Fig. II-2B). Vitronectin and fibrinogen 
exhibited only marginal binding activities, even at the highest α8β1 integrin 
concentration examined. The low binding affinities of α8β1 integrin toward fibronectin, 
vitronectin and fibrinogen were not due to inactivation of these adhesive proteins 
because they retained their abilities to bind to their specific integrin receptors, namely 
α5β1, αVβ3 and αIIbβ3, respectively (Fig. II-2C-E). Taken together, these results 
demonstrate that nephronectin is a preferred ligand for α8β1 integrin among 
RGD-containing proteins known to bind to α8β1 integrin. 
 
The RGD-Linker Segment of Nephronectin Harbors the α 8β 1 Binding 
Activity—Since the RGD motif is situated within the linker segment connecting the 
N-terminal EGF-like repeats and the C-terminal MAM domain, we examined whether the 
RGD-linker segment could recapitulate the high-affinity binding to α8β1 integrin. To this 
end, we expressed the RGD-linker in mammalian cells or as a GST fusion protein in 
bacteria (Fig. II-3A). We also expressed the C-terminal MAM domain in mammalian 
cells and a GST fusion protein with a C-terminal extension of the PRGDV sequence of 
nephronectin in bacteria as controls. The RGD-linker expressed in 293-F cells gave a 
broad band migrating at 35-60 kDa upon SDS-PAGE, while the RGD-linker expressed as 
a GST fusion protein in bacteria gave a sharp band at 50 kDa (Fig. II-3B). The apparent 
heterogeneity of the RGD-linker expressed in mammalian cells was probably caused by 
extensive O-linked glycosylation because the RGD-linker was strongly reactive with 
PNA, a lectin that recognizes mucin-type O-linked sugar chains (Fig. II-3B). The 
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Fig. II-3. Expression and 
purification of nephronectin 
fragments. A, schematic 
diagrams of full-length 
nephronectin (NN) and its 
fragments. RGD-linker and 
RGD-linker (GST), the central 
RGD-containing linker 
segments expressed in 
mammalian and bacterial 
expression systems, 
respectively; PRGDV, a short 
RGD-containing peptide 
modeled after nephronectin and 
expressed as a GST fusion 
protein (see Fig. II-4A for the 
peptide sequence). The 
arrowheads indicate the 
positions of the RGD motif. B, 
purified recombinant proteins were analyzed by SDS-PAGE in 7-15% gradient (left and center panels) and 
12% (right panels) gels, followed by CBB staining, immunoblotting with an anti-FLAG mAb or lectin 
blotting with PNA. The quantities of proteins loaded were: 0.5 µg (for CBB staining) and 0.1 µg (for 
blotting with anti-FLAG and PNA) in the left and center panels; 1 µg in the right panel. 
 
recombinant MAM domain, with a predicted mass of 17 kDa, gave a major band 
migrating at ~20 kDa under both reducing and non-reducing conditions (Fig. II-3B). 
Additional bands were detected at 40 and 60 kDa by immunoblotting with an anti-FLAG 
mAb under non-reducing conditions, indicating that the MAM domain tends to form 
dimers and trimers that are resistant to dissociation under the denaturing conditions used, 
i.e., boiling in the presence of SDS. 
The purified RGD-linkers were assayed for their binding activities towards α8β1 
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integrin (Fig. II-4). Not only the full-length nephronectin but also the RGD-linkers, 
irrespective of the cells used for recombinant protein expression, bound strongly to α8β1 
integrin, whereas the MAM domain did not show any binding activity. The titration 
curves of the RGD-linkers were essentially the same as that of full-length nephronectin 
(Fig. II-4), yielding dissociation constants of 0.2-0.3 nM (Table II-1). Furthermore, the 
PRGDV peptide expressed at the C-terminus of GST had only marginal, if any, binding 
activity toward α8β1 integrin, even though it contained the RGD motif. Since the 
GST-fused PRGDV peptide retained the ability to bind to αVβ3 integrin (see Fig. II-5D), 
these results indicate that the RGD motif is necessary but not sufficient for binding of 
nephronectin to α8β1 integrin. We also performed saturation binding assays in the 
presence of 1 mM Ca2+ and Mg2+, instead of 1 mM Mn2+, and confirmed that the 
activities of the RGD-linkers to bind to α8β1 integrin were the same as that of full-length 
nephronectin (data not shown). These results indicate that the linker segment is sufficient 
 
Fig. II-4. Binding activities of α8β1 
integrin to nephronectin and its 
fragments. Titration curves of α8β1 
integrin bound to full-length nephronectin 
(NN, closed squares), the RGD-linker 
segments expressed in 293-F cells 
(RGD-linker, closed triangles) and E. coli 
(RGD-linker (GST), open triangles), the 
MAM domain (MAM, closed diamonds) 
and the PRGDV peptide expressed as a 
GST-fusion protein in E. coli. (PRGDV 
(GST), open circles). The assays were 
performed as described in the legend to Fig. 
II-2B. The results represent the means of 
duplicate determinations. 
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for the high-affinity recognition of nephronectin by α8β1 integrin. However, the PRGDV 
peptide modeled after nephronectin was barely active in binding to α8β1 integrin, even 
at the highest α8β1 integrin concentration tested, suggesting that in addition to the RGD 
motif, the linker segment contains a region that potentiates the binding activity of 
nephronectin to α8β1 integrin. 
 
TABLE II-1. Dissociation constants of α8β1 integrin toward nephronectin and its deletion 
mutants 
 
 
 
 
 
 
aValues represent the means ± SD of three 
independent experiments. 
bThe dissociation constant was not determined 
owing to the absence of significant binding. 
cThe dissociation constants were not determined 
owing to only partial saturation at the highest 
integrin concentration examined. 
 
 
 
 
 
 
 
 
 
Identification of the Region within the Linker Segment that Warrants 
High-affinity Binding to α8β1 Integrin—To explore the region within the linker 
segment that potentiates the RGD-dependent binding of nephronectin to α8β1 integrin, 
Ligands Kd (nM)a 
NN 
RGD-linker 
MAM 
RGD-linker (GST) 
PRGDV (GST) 
LS/366-414 
LS/378-414 
LS/366-393 
LS/378-407 
LS/378-403 
LS/378-401 
LS/378-399 
LS/378-393 
LS/381-407 
LS/391-407 
LS/395-407 
0.28±0.01 
0.23±0.05 
ND (-)b 
0.22±0.04 
NDc 
0.32±0.03 
0.33±0.02 
NDc 
0.33±0.01 
0.44±0.04 
7.1±0.6 
13±1 
NDc 
0.42±0.08 
NDc 
NDc 
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we produced a series of RGD-linker deletion mutants as GST fusion proteins (Fig. II-5A). 
Since the linker segment expressed as a GST fusion protein was fully competent in 
high-affinity binding to α8β1 integrin and devoid of the mucin-like sugar chains that 
have been predicted to attach to the N-terminal two-thirds of the linker segment (based 
on Net-O-Glyc; http://www.cbs.dtu.dk/services/NetOGlyc/ (Hansen et al., 1998)), we 
first produced a deletion mutant comprising the C-terminal one-third of the linker 
segment, designated linker segment (LS)/366-414. LS/366-414 bound avidly to α8β1 
integrin with a dissociation constant of 0.32 ± 0.03 nM, comparable to that of the 
full-length RGD-linker (Fig. II-5C and Table II-1). Given the retention of the full α8β1 
binding activity within LS/366-414, we employed this fragment as a template for the 
production of a series of deletion mutants (Fig. II-5A). The authenticities of the resulting 
mutant proteins were verified by SDS-PAGE (Fig. II-5B).  
The purified mutant proteins were assayed for their binding activities toward α8β1 
integrin. LS/378-414, a mutant protein lacking the N-terminal 12 amino acid residues of 
LS/366-414, was capable of binding to α8β1 integrin with a comparable potency to that 
of LS/366-414 (Fig. II-5C and Table II-1). On the other hand, LS/366-393, a deletion 
mutant lacking the C-terminal 21 amino acid residues, was barely active in binding to 
α8β1 integrin, although the RGD motif remained intact in this mutant. These results 
indicate that the C-terminal 21 residues (394-414) are required for the high-affinity 
binding of nephronectin to α8β1 integrin. To further narrow down the residues required 
for the high-affinity binding to α8β1 integrin, we produced a series of C-terminal 
deletion mutants of LS/378-414, i.e., LS/378-407, LS/378-403, LS/378-401, LS/378-399 
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and LS/378-393 (Fig. II-5A). Among these C-terminal deletion mutants, LS/378-407 and 
LS/378-403 retained integrin binding activities comparable to that of LS/378-414, while 
LS/378-401, LS/378-399 and LS/378-393 exhibited stepwise reductions in their integrin 
binding activities, resulting in an almost complete loss of the activity after deletion of 
residues 394-414 (Fig. II-5C and Table II-1). We also assessed the binding activities of 
α8β1 integrin to the C-terminal deletion mutants of the RGD-linker in the presence of 1 
mM Ca2+ and Mg2+, insead of 1 mM Mn2+. The stepwise reductions of the binding 
activities of α8β1 integrin to LS/378-401, LS/378-399 and LS/378-393 were reproduced 
in the assays performed in the presence of Ca2+ and Mg2+, although the binding activities 
of the mutants were less pronounced than those attained in the presence of Mn2+ (data not 
shown). Since LS/378-403 retained almost full activity, these results indicate that 
residues 394-403 (DLFEIFEIER) are involved in the high-affinity binding to α8β1 
integrin. 
The RGD motif has been shown to be a prerequisite for the integrin binding activity 
of nephronectin (Brandenberger et al., 2001; Morimura et al., 2001). To confirm the 
critical role of the RGD motif, we produced a series of N-terminal deletion mutants of 
LS/378-407, i.e., LS/381-407, LS/391-407 and LS/395-407. Among these mutants, 
LS/391-407 and LS/395-407, both lacking the RGD motif but retaining the 
(D)LFEIFEIER sequence, were barely active in binding to α8β1 integrin, whereas 
LS/381-407, an N-terminal deletion mutant possessing both the RGD motif and the 
DLFEIFEIER sequence, was fully active in binding to α8β1 integrin (Fig. II-5C). Taken 
together, these results indicate that both the RGD motif and the DLFEIFEIER sequence 
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Fig. II-5. Binding activities of α8β1 integrin toward deletion mutants of the RGD-linker segment. A, 
amino acid sequences of deletion mutants of the RGD-linker segment. The mutant proteins were expressed 
in bacteria as GST fusion proteins. The RGD motif is indicated in bold. The vector-derived sequences are 
shown in italics. B, SDS-PAGE profiles of the mutant proteins (1 µg/lane) stained with CBB. The 
positions of molecular size markers are shown in the left margin. C and D, binding activities of α8β1 (C) 
and αVβ3 (D) integrins to the mutant proteins. Microtiter plates were coated with the individual mutant 
proteins (10 nM) and incubated with the integrins at the indicated concentrations. Bound integrins were 
quantified as described in the Experimental Procedures. The results represent the means of duplicate 
determinations. 
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at 10 residues to the C-terminal side of the RGD motif are required for the high-affinity 
binding of nephronectin to α8β1 integrin.  
In contrast to the clear dependence of α8β1 integrin on both the RGD motif and the 
DLFEIFEIER sequence for binding to nephronectin, the binding activities of the mutant 
fragments to αVβ3 integrin, another integrin known to bind to nephronectin 
(Brandenberger et al., 2001), remained almost unchanged regardless of the presence or 
absence of the DLFEIFEIER sequence, as long as the fragments contained the RGD 
motif (Fig. II-5D). Therefore, the DLFEIFEIER sequence is involved in nephronectin 
recognition by α8β1 integrin but not αVβ3 integrin. 
 
Identification of Critical Amino Acid Residues in the DLFEIFEIER Sequence—To 
further define the amino acid residues in the DLFEIFEIER sequence that are critical for 
the high-affinity binding to α8β1 integrin, we produced a series of alanine substitution 
mutants of LS/378-403, in which individual amino acid residues of the DLFEIFEIER 
sequence were substituted with alanine (Fig. II-6A), except for Asp-394 that is not 
conserved in nephronectin among different species (see Fig. II-13). Although the L395A, 
E397A, I398A and R403A substitutions did not cause any detectable decreases in the 
integrin binding activity of LS/378-403, the E400A, I401A and E402A mutants exhibited 
moderate reductions (Fig. II-6B), resulting in 2-, 3- and 5-fold decreases in their integrin 
binding affinities, respectively, compared with that of LS/378-403 (Table II-2). Small, 
yet reproducible, decreases were also observed for the F396A and F399A mutants. 
Given the involvement of two glutamic acid residues (Glu-400 and Glu-402) in 
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nephronectin recognition by α8β1 integrin, we substituted both of these Glu residues 
with alanine. The resulting double-substitution mutant showed a significant decrease in 
the α8β1 binding activity, although no such additive effects were found when E397A 
substitution was combined with E400A or E402A substitution. Therefore, the marked 
 
Fig. II-6. Effects of alanine substitutions 
within the LFEIFEIER sequence on the 
integrin binding activity. A, amino acid 
sequences of LS/378-403 mutants with alanine 
substitutions. The mutant proteins are 
designated by the substituted residues. B and C, 
binding activities of LS/378-403 and its 
alanine-substituted mutants toward α8β1 (B) 
and αVβ3 integrins. Microtiter plates were 
coated with the alanine-substituted mutants 
and incubated with integrins (1 or 3 nM) in the 
presence of 1 mM Mn2+. Bound integrins were 
quantified as described in the Experimental 
Procedures. The results represent the means of 
duplicate determinations. 
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loss of α8β1 binding activity upon the E400/402A double substitutions was not simply 
due to an extra loss of negative charges but due to the involvement of both residues in 
binding to α8β1 integrin. Despite the substantial impact of the E400/402A double 
mutations on binding to α8β1 integrin, these mutations did not compromise the binding 
affinity of LS/378-403 toward αVβ3 integrin (Fig. II-6C), underscoring a role of 
Glu-400/Glu-402 in the high-affinity binding of nephronectin to α8β1 integrin. Given 
that I401A substitution also caused a moderate decrease in the α8β1 integrin binding 
activity, these results raised the possibility that the EIE sequence serves as an auxiliary 
recognition site within nephronectin that directly interacts with α8β1 integrin in concert 
with the RGD motif. 
 
 
TABLE II-2. Dissociation constants of α8β1 integrin toward LS/378-403 after alanine 
scanning mutagenesis 
 
 
 
 
 
 
 
aValues represent the means ± SD of three independent 
experiments. 
bThe dissociation constant was not determined owing to 
only partial saturation at the highest integrin 
concentration examined. 
 
 
 
 
 
 
Ligands Kd (nM)a 
LS/378-403 
L395A 
F396A 
E397A 
I398A 
F399A 
E400A 
I401A 
E402A 
R403A 
E397/400A 
E397/402A 
E400/402A 
0.44±0.04 
0.44±0.08 
0.84±0.22 
0.42±0.06 
0.38±0.04 
0.72±0.12 
0.95±0.12 
1.3±0.2 
2.5±0.4 
0.51±0.08 
0.81±0.23 
4.4±0.6 
NDb 
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Effects of the LFEIFEIER Peptide on the Interaction of α8β1 Integrin with 
Nephronectin—To address the role of the LFEIFEIER sequence as one of the bipartite 
α8β1 integrin recognition sites in nephronectin, we examined whether a synthetic 
peptide modeled after the sequence was able to inhibit the interaction of nephronectin 
with α8β1 integrin. We synthesized a 23-mer peptide encompassing the region from the 
RGD motif to the LFEIFEIER sequence and its mutant forms with RGD→RGE and 
EIE→AIA substitutions (Fig. II-7A), and examined their effects on the binding of 
nephronectin to α8β1 integrin (Fig. II-7B). The 23-mer peptide strongly inhibited the 
binding of α8β1 integrin to nephronectin with an IC50 of ~0.6 nM (Fig. II-7B and Table  
 
Fig. II-7. Inhibition of α8β1 integrin 
binding to nephronectin by synthetic 
peptides. A, amino acid sequences of the 
synthetic peptides tested. The RGD motifs 
are shown in bold. B, α8β1 integrin (1 nM) 
was incubated on microtiter plates coated 
with full-length nephronectin (10 nM) in the 
presence of increasing concentrations of 
synthetic peptides. To prevent precipitation 
of the peptides, the integrin binding assays 
were performed in the presence of 10% 
DMSO. The amounts of bound α8β1 
integrin are shown as percentages relative to 
the control, in which α8β1 integrin was 
incubated on nephronectin-coated plates in 
the presence of 10% DMSO. The results 
represent the means of duplicate 
determinations. Closed diamonds, 23 AA 
(23-mer containing both the RGD motif and 
the LFEIFEIER sequence); closed squares, 
23 AA-AIA (23-mer with the E400/402A double mutation); closed triangles, 23 AA-RGE (23-mer with 
the RGD → RGE mutation); closed circles, NN-RGD; open diamonds, NN-RGE; open squares, NN-EIE; 
open circles, NN-RGD plus an equal amount of NN-EIE. 
B 
A 
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TABLE II-3. Inhibition of α8β1-nephronectin interaction by synthetic peptides 
 
 
 
 
aDetermined based on the data in Fig. 5B. The values 
represent the means ± SD of three independent 
determinations. 
bNot determined. 
 
 
 
II-3). Since this IC50 value was comparable to the dissociation constant of α8β1 integrin 
for nephronectin, the 23-mer peptide appeared to be fully competent in the high-affinity 
binding to α8β1 integrin. Substitution of the EIE motif with AIA resulted in an ~10-fold 
decrease in the potency of the peptide to inhibit the integrin-nephronectin interaction, 
while substitution of the RGD motif with RGE resulted in an ~1000-fold decrease. These 
results indicate that, although both the RGD and EIE motifs are involved in the binding 
of α8β1 integrin to nephronectin, the contribution of the RGD motif is much greater than 
that of the EIE motif in securing the association of the synthetic peptide with α8β1 
integrin. We also synthesized two shorter peptides harboring the RGD or EIE motif (Fig. 
II-7A), and assessed their potencies to inhibit the binding of α8β1 integrin to 
nephronectin. The PRGDVFIP peptide containing only the RGD motif was moderately 
inhibitory toward the binding with an IC50 of 1.2 µM, ~2000-fold less potent than the 
23-mer peptide. On the other hand, the LFEIFEIER peptide containing only the EIE 
motif was barely inhibitory, in good agreement with the dominant contribution of the 
RGD motif over the EIE motif in the association of the 23-mer peptide with α8β1 
Peptides IC50 (nM)a 
23 AA 
23 AA-AIA 
23 AA-RGE 
NN-RGD 
NN-RGE 
NN-EIE 
NN-RGD + NN-EIE 
0.63±0.14 
7.0±0.9 
650±50 
1200±200 
NDb 
NDb 
1300±500 
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integrin. The LFEIFEIER peptide did not potentiate the inhibitory activity of the 
PRGDVFIP peptide when mixed with an equimolar amount of the RGD-containing 
peptide, suggesting that the RGD and EIE motifs need to be aligned in tandem within the 
same polypeptide to exert their potency to competitively inhibit the binding of α8β1 
integrin to nephronectin. 
 
Trans-complementation of Activity between the RGD and EIE Motifs—To further 
explore the role of the EIE motif in the high-affinity binding of nephronectin to α8β1 
integrin, we employed trans-complementation assays (Obara et al., 1988) using GST 
fusion proteins containing only the RGD (LS/378-393) or EIE (LS/395-407) motif. Plates 
were coated with LS/378-393, followed by a second coating with increasing 
concentrations of LS/395-407, and then subjected to integrin binding assays. Plates 
coated with LS/378-407 or GST were also subjected to a second coating with 
LS/395-407 and subsequent integrin binding assays as controls. Although LS/378-393 
alone was inactive in binding to α8β1 integrin, it became active upon the second coating 
with increasing concentrations of LS/395-407 (Fig. II-8A). A second coating with 
LS/395-407 at >10 nM also endowed GST with integrin binding activity. However, the 
activity restored to LS/378-393 was significantly greater than the activity restored to the 
GST-coated plates, indicating that close juxtaposition of LS/395-407 harboring the EIE 
motif and LS/378-393 harboring the RGD motif synergistically potentiated their integrin 
binding activities. Saturation integrin binding assays demonstrated that the affinity of 
LS/378-393 for α8β1 integrin was significantly enhanced upon a second coating with  
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Fig. II-8. Trans-complementation assays 
of recombinant nephronectin fragments. 
A, 96-well microtiter plates were coated 
with LS/378-407 (closed squares), 
LS/378-393 (open squares) and GST (open 
triangles), washed with PBS and then 
coated a second time with increasing 
concentrations of LS/395-407 lacking the 
RGD motif. The plates were subjected to 
integrin binding assays using 1 nM α8β1 
integrin as described in the Experimental 
Procedures. B, titration curves of α8β1 
integrin bound to substrates coated with 
LS/378-393, followed by a second coating 
with LS/395-407 at 0 nM (diamonds), 1 nM 
(squares), 10 nM (triangles) and 100 nM 
(circles). Note that the affinities of α8β1 
integrin for LS/378-393 are synergistically 
enhanced by the presence of LS/395-407. C, 
microtiter plates were coated with 10 nM 
LS/378-393, washed with PBS and then 
coated a second time with increasing 
concentrations of LS/395-407 (closed 
diamonds), LS/395-407(E400/402A) 
(closed squares) and GST (open triangles). 
The plates were subjected to integrin 
binding assays using 1 nM α8β1 integrin as 
described in the Experimental Procedures. 
D, trans-complementation activities of the 
RGD motif and the LFEIFEIER sequence to 
bind to αVβ3 integrin (1 nM) was assessed 
as in A. E, the requirement of the Glu-400 
and Glu-402 residues was assessed by 
trans-complementation assays using αVβ3 
integrin as probes. Note that the 
LFEIFEIER sequence has nothing to do 
with the enhancement of the interaction of 
αVβ3 integrin. The results represent the 
means of duplicate determinations. 
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increasing concentrations of LS/395-407 (Fig. II-8B) and reached a dissociation constant 
of 1.2 nM, which was comparable to that of LS/378-407 containing both the RGD and 
EIE motifs within the same polypeptide chain. These results support the conclusion that 
nephronectin has a bipartite α8β1 integrin binding site comprising the RGD and EIE 
motifs, of which the EIE motif plays an auxiliary role in stabilizing the complex of 
nephronectin and α8β1 integrin. To further confirm the importance of the EIE motif in 
the high-affinity binding of α8β1 integrin to nephronectin, we performed 
trans-complementation assays using an LS/395-407 mutant in which the two glutamic 
acid residues in the EIE motif were replaced with alanine, designated 
LS/395-407(E400/402A). The LS/395-407 mutant was incapable of potentiating the 
integrin binding activity of LS/378-393, even at the highest concentrations used (Fig. 
II-8C). No such synergism was observed in trans-complementation assays with αVβ3 
integrin (Fig. II-8D and E), consistent with the specific role of the EIE motif in selective 
recognition of nephronectin by α8β1 integrin. 
 
Involvement of the EIE Motif in α8β1 Integrin-dependent Cell Adhesion—The role 
of the EIE motif in nephronectin recognition by α8β1 integrin was further assessed by 
cell adhesion assays. To this end, we transfected HT1080 human fibrosarcoma cells with 
an α8 integrin cDNA and isolated stable transfectants expressing α8 integrin. Expression 
of the exogenous α8 integrin in the transfectants (designated HT1080-A8 cells) was 
verified by flow cytometry (Fig. II-9A) and immunoblotting (Fig. II-9B). HT1080-A8 
cells were readily adherent to nephronectin upon coating on substrates at >1 nM, while 
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Fig. II-9. Establishment of HT1080 cells stably expressing human α8 integrin. A, flow cytometric 
analyses of α8 integrin on HT1080 cells. Control and α8 integrin-transfected HT1080 cells (the latter 
designated HT1080-A8 cells) were incubated with an anti-human α8 mAb (7A5) and stained with an 
Alexa Fluor® 488-conjugated secondary antibody. The expressions of α8 integrin are shown as gray lines, 
while the black areas indicate the negative controls incubated with mouse IgG instead of an anti-α8 mAb. 
B, cell lysates were subjected to SDS-PAGE, followed by immunoblotting with an anti-human α8 integrin 
mAb (10A8) (upper panel) or anti-actin polyclonal antibody (lower panel). C, HT1080 (closed circles) 
and HT1080-A8 (open circles) cells were incubated at 37°C for 30 min on 96-well microtiter plates coated 
with increasing concentrations of nephronectin. Adherent cells were fixed and stained as described in the 
Experimental Procedures. The results represent the means ± SE?of triplicate assays. 
 
untransfected HT1080 cells did not adhere to nephronectin even after coating on 
substrates at 40 nM (Fig. II-9C), confirming that the adhesion of HT1080-A8 cells to 
nephronectin was dependent on α8β1 integrin. 
To assess the α8β1 integrin binding activities of the RGD-linker segment and its 
mutant proteins on the basis of cell adhesion assays, HT1080-A8 cells were allowed to 
adhere to substrates coated with increasing concentrations of the linker segment and its 
mutants with deletions and/or amino acid substitutions. The RGD-linker was equally 
active to intact nephronectin in promoting the adhesion of HT1080-A8 cells, while 
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LS/378-403, which harbors both the RGD and EIE motifs and retains comparable α8β1 
integrin binding activity to that of intact nephronectin, was significantly less active than 
intact nephronectin and the control RGD-linker in promoting the adhesion of 
HT1080-A8 cells (Fig. II-10A). The difference between the cell-adhesive activities of the 
full-length RGD-linker and LS/378-403 could be due to the involvement of 
non-integrin-type adhesion receptors that possibly recognize the N-terminal region of the 
linker segment absent from LS/378-403. LS/378-393, which contains the RGD motif but 
not the EIE motif, was significantly less active than LS/378-403. A similar reduction in 
cell-adhesive activity was also observed with LS/378-393 in cell adhesion assays  
 
Fig. II-10. Cell-adhesive activities of recombinant nephronectin and its fragments. A, HT1080-A8 
cells were incubated at 37°C for 30 min on 96-well microtiter plates coated with increasing concentrations 
of nephronectin (NN, closed diamonds), the RGD-linker segment expressed as a GST fusion protein 
(RGD-linker (GST), closed squares), LS/378-403 (closed triangles), LS/378-393 (closed circles), 
LS/378-403(E400/402A) (open triangles) and GST (open circles). Adherent cells were fixed and stained 
as described in the Experimental Procedures. The results represent the means ± SE?of triplicate assays. B, 
representative images of HT1080-A8 cells adhering to substrates coated with the indicated proteins. Bar = 
50 µm. 
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performed in the presence of Mn2+ (data not shown), together corroborating the 
importance of the EIE motif in the potent cell-adhesive activity of nephronectin. In 
support of the critical role of the EIE motif, alanine substitution of the two Glu residues 
in the EIE motif of LS/378-403 resulted in a marked reduction in the cell-adhesive 
activity, leading to comparable activity to that of LS/378-393. 
Integrin-mediated adhesion has been shown to transduce signals that induce 
reorganization of the actin cytoskeleton, thereby leading to cell spreading on substrates. 
Cells adhering to LS/378-403 exhibited well-spread polygonal shapes at coating 
concentrations of >40 nM, while cells were poorly spread on LS/378-393 and 
LS/378-403(E400/402A) even after coating at 320 nM (Fig. II-10B). These results 
indicate that LS/378-403 is competent in stimulating actin cytoskeleton reorganization 
through binding to α8β1 integrin, and that the EIE motif within the fragment is 
indispensable for stimulation of integrin-mediated signaling events. Similar results were 
obtained in cell adhesion assays using K562 erythroleukemic cells stably transfected with 
chick α8 integrin (data not shown). 
The importance of the EIE motif for α8β1 integrin-dependent cell adhesion to 
nephronectin was further addressed by cell adhesion inhibition assays using synthetic 
peptides. Adhesion of HT1080-A8 cells to nephronectin was strongly inhibited by the 
23-mer peptide with an apparent IC50 of 3.8 µM (Fig. II-11). Substitution of the EIE 
motif with AIA resulted in an ~30-fold decrease in the potency of the 23-mer peptide to 
inhibit the cell adhesion on nephronectin, while substitution of the RGD motif to RGE 
resulted in an almost complete loss of the inhibitory activity. These results were in line 
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with those obtained in the peptide inhibition assays of direct binding of α8β1 integrin to 
nephronectin (Fig. II-7), underscoring the greater contribution of the RGD motif over the 
EIE motif in stabilizing the association of nephronectin with α8β1 integrin. Shorter 
peptides containing either the RGD or EIE motif did not exert inhibitory effects, even at 
the highest concentrations examined, consistent with the requirement for both the RGD 
and EIE motifs within the same peptide for efficient inhibition of the interaction between 
nephronectin and α8β1 integrin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.II-11. Inhibition of α8β1 integrin-mediated cell adhesion by synthetic peptides. HT1080-A8 cells 
were incubated on plates coated with 3 nM nephronectin for 30 min in the presence of increasing 
concentrations of the following synthetic peptides: 23-mer containing both the RGD motif and 
LFEIFEIER sequence (23 AA, closed diamonds); 23-mer with the E400/402A double mutation (23 
AA-AIA, closed squares); 23-mer with the RGD→RGE mutation (23 AA-RGE, closed triangles); 
PRGDVFIP (RGD, closed circles); and LFEIFEIER (EIE, open diamonds). Adherent cells were fixed and 
stained as described in the Experimental Procedures. Adhesion of cells in the presence of 0.5% DMSO 
was taken as 100%. The results represent the means ± SE of triplicate determinations. 
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II-5 Discussion 
 
In the present study, I investigated the interactions of α8β1 integrin with a panel of 
RGD-containing proteins and found that α8β1 integrin binds strongly and preferentially 
to nephronectin with an ~100-fold higher affinity than those to other RGD-containing 
proteins including fibronectin and vitronectin. In addition to the RGD-containing 
proteins examined, α8β1 integrin has been shown to bind to osteopontin, the 
latency-associated peptide of TGF-β, tenascin-W, MAEG and QBRICK/Frem1 in 
RGD-dependent manners (Denda et al., 1998b; Lu et al., 2002; Kiyozumi et al., 2005; 
Osada et al., 2005; Scherberich et al., 2005). Although the binding affinities for these 
ligand proteins remain to be determined, the following observations, together with my 
data, indicate that nephronectin is the most preferred ligand for α8β1 integrin with the 
highest binding affinity. Recombinant α8β1 integrin bound to nephronectin, but not to 
vitronectin or osteopontin, in far-western blotting assays with tissue extracts 
(Brandenberger et al., 2001). Mice deficient in nephronectin expression displayed kidney 
agenesis or hypoplasia and were associated with a marked reduction in GDNF expression 
in the metanephric mesenchyme, resembling the phenotypes observed in mice deficient 
in α8  integrin expression (Muller et al., 1997; Linton et al., 2007). Consistent with the 
similarities in phenotypes between the nephronectin-deficient and α8 integrin-deficient 
mice, the distribution patterns of nephronectin in embryonic lungs and kidneys 
overlapped with those of α8β1 integrin (Muller et al., 1997; Brandenberger et al., 2001; 
Wagner et al., 2003; Manabe et al., 2008). Recently, my collaborators examined the 
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distributions of α8β1 ligands by integrin overlay assays using frozen mouse tissues and 
found that the signals for α8β1 ligands significantly overlapped with those for 
nephronectin visualized by immunohistochemistry (M. Takeichi and D. Kiyozumi, 
unpublished observations), further supporting the possibility that nephronectin is the 
physiological ligand for α8β1 integrin with the highest binding affinity among the 
RGD-containing proteins identified to date. 
My results showed that the RGD-linker segment connecting the N-terminal five 
EGF-like repeats and the C-terminal MAM domain harbors full activity to bind to α8β1 
integrin. Although the RGD motif in the linker segment is a prerequisite for the integrin 
binding activity, several lines of evidence indicate that the LFEIFEIER sequence at ~10 
amino acid residues downstream of the RGD motif is required for the high-affinity 
binding of the linker segment to α8β1 integrin. First, deletion of the LFEIFEIER 
sequence from the linker segment resulted in a dramatic loss of the integrin binding 
activity, even though the RGD motif remained unperturbed. Second, 
trans-complementation assays demonstrated that almost full binding activity toward 
α8β1 integrin was restored to LS/378-393, a deletion mutant containing only the RGD 
motif, upon a second coating with LS/395-407, another deletion mutant containing only 
the LFEIFEIER sequence. Third, a synthetic 23-mer peptide covering the region from the 
RGD motif to the LFEIFEIER sequence strongly inhibited the binding of α8β1 integrin 
to nephronectin, while shorter peptides containing either the RGD motif or the 
LFEIFEIER sequence were only poorly inhibitory. Taken together, these results point to 
the conclusion that the LFEIFEIER sequence synergizes with the RGD motif to ensure 
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the high-affinity binding of nephronectin to α8β1 integrin. 
Alanine scanning mutagenesis of the LFEIFEIER sequence revealed that two Glu 
residues within the sequence, i.e., Glu-400 and Glu-402, play critical roles in the synergy 
of this sequence with the RGD motif. Alanine substitution of these individual Glu 
residues resulted in moderate decreases in the integrin binding activity of the linker 
segment, while double substitution of both Glu residues severely impaired the activity. In 
support of the critical roles of these two Glu residues, E400/402A double mutation 
abrogated the activity of LS/395-407, a mutant fragment containing the LFEIFEIER 
sequence but not the RGD motif, to potentiate the integrin binding activity of 
LS/378-393, a fragment containing only the RGD motif, in trans-complementation 
assays. In addition to these two Glu residues, several hydrophobic residues in the 
LFEIFEIER sequence may also be involved in nephronectin recognition by α8β1 
integrin, since alanine substitution of Phe-396, Phe-399 and Ile-401 caused moderate 
reductions in the integrin binding activity of the RGD-linker segment. Recently, DiCara 
et al. (DiCara et al., 2007) reported that hydrophobic residues downstream of the RGD 
motif are involved in potentiation of the binding affinity of αVβ6 integrin toward 
RGD-containing oligopeptides modeled after its natural ligands, i.e., the coat protein of 
foot-and-mouth disease virus and the latency-associated peptides of TGFβ proteins. They 
demonstrated that oligopeptides capable of binding to αVβ6 integrin with high affinities 
had an RGDLXXL or RGDLXXI motif, of which LXXL/I forms a stable helix with two 
hydrophobic residues (i.e., Leu and Leu/Ile) exposed almost in apposition on one face of 
the helix, suggesting that these hydrophobic residues, together with the RGD motif, 
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directly interact with the ligand binding pocket of αVβ6 integrin (DiCara et al., 2007). 
Given the similarity between nephronectin and the natural ligands for αVβ6 integrin in 
the requirement for a post-RGD sequence for high-affinity integrin binding, the 
hydrophobic residues within the LFEIFEIER sequence may also be directly involved in 
ligand recognition by α8β1 integrin. Consistent with this possibility, the LFEIFEIER 
sequence was predicted to form a helix by PAPIA, an algorithm for protein secondary 
structure prediction (Akiyama et al., 1998).  
The requirement for an auxiliary site for selective high-affinity recognition of 
RGD-containing ligands by integrins has been documented for other integrin-ligand pairs. 
Fibronectin has been the prototype for such ligands harboring a so-called synergy site, 
requiring not only the tenth type III module containing the RGD motif but also the 
preceding type III module (FNIII9) for its high-affinity binding to α5β1 integrin (Aota et 
al., 1994; Redick et al., 2000). The PHSRN sequence in the FNIII9 module was shown to 
be critical for the synergistic activity (Aota et al., 1994). The natural ligands for αVβ6 
integrin also possess such an auxiliary site immediately on the C-terminal side of the 
RGD motif as described above (DiCara et al., 2007). Despite the available evidence, 
including the data in the present study, for the requirement of synergy sites for 
high-affinity binding of RGD-containing ligands to integrins, it remains to be elucidated 
how the synergy sites potentiate the binding affinities between integrins and their 
RGD-containing ligands. This is in striking contrast to the interactions of the RGD motif 
with integrins, since determination of the crystal structures of integrins complexed with 
cyclic RGD-like peptides revealed that the arginine side chain of the RGD motif fits into 
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a cleft in the β-propeller domain of integrin α subunits, while the aspartate side chain 
coordinates the divalent cation at the metal ion-dependent adhesion site (designated 
MIDAS) of β subunits (Xiong et al., 2002; Xiao et al., 2004). It should be noted, 
however, that in addition to the residues defined by the crystal structures to directly 
interact with the RGD motif, a group of residues located on the upper or side faces of the 
β-propeller domain of the α subunits have also been implicated in ligand binding by 
integrins. Specifically, epitope mapping of function-blocking anti-integrin antibodies as 
well as mutational analyses of the integrin α subunits indicated that the ligand binding 
specificities of α5β1 and αVβ1 integrins were dependent on residues in blades 2 and 3 of 
the β-propeller domain of their α subunits (Humphries et al., 2000; Mould et al., 2000; 
Humphries et al., 2003), of which Tyr-208 and Ile-210 in blade 3 of the integrin α5 
subunit were shown to recognize the synergy site of fibronectin (Mould et al., 2003). 
Furthermore, mutations that disrupted ligand binding by αIIbβ3 integrin were found to 
be clustered on the top or side of the β-propeller domain of the αIIb subunit, and mostly 
located within blades 2 and 3 (Kamata et al., 2001). Similarly, the acidic clusters located 
on blade 3 of the β-propeller domain of the α7 subunit were shown to determine the 
ligand-binding specificity of α7β1 integrin (von der Mark et al., 2007). Given the 
involvement of the upper or side faces of the β-propeller domain, particularly those 
involving blades 2 and 3, in the high-affinity ligand recognition by integrins, the same 
regions of the β-propeller domain of the α8 subunit may be involved in recognition of 
the LFEIFEIER sequence, thereby ensuring the high-affinity binding of nephronectin to 
α8β1 integrin. It is interesting to note that the residues comprising the upper or side 
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loops of the β-propeller domain differ significantly among RGD-recognizing integrins. 
The α8 integrin subunit is unique in that it possesses evolutionarily conserved basic 
amino acid clusters at the loops connecting blades 1 and 2 and within blade 3 of its 
β-propeller domain (Fig. II-12), the latter being equivalent to the loops involved in the 
ligand-binding specificities of α5β1 and α7β1 integrins (Mould et al., 2003; von der 
Mark et al., 2007). Since two Glu residues within the LFEIFEIER sequence are required 
for high-affinity binding of nephronectin to α8β1 integrin and evolutionarily conserved 
among vertebrates (Fig. II-13), it is tempting to speculate that the cluster of basic amino 
acid residues in the loop either between blades 1 and 2 or within blade 3 of the α8 
β-propeller domain form salt bridges with the acidic residues of the EIE motif, thereby 
sustaining the high-affinity recognition of nephronectin by α8β1 integrin. 
Synthetic RGD-containing peptides have been widely used as probes that specifically 
block the interactions of RGD-binding integrins with their ligands in a variety of 
biochemical and cell biological assays (Pierschbacher and Ruoslahti, 1984; Akiyama and 
Yamada, 1985; Manabe et al., 1997). However, the RGD peptides are equally inhibitory 
toward all RGD-binding integrins, and therefore cannot be used as specific probes for the 
biological consequences of interactions between defined RGD-binding integrins and their 
physiological ligands. Furthermore, the absence of the synergy sequences that potentiate 
the integrin binding affinities of RGD-containing ligands leads to a requirement for high 
concentrations of RGD peptides to block the integrin-ligand interactions. For instance, 
RGD peptide concentrations of >1 mM are required to effectively block α5β1-mediated 
cell adhesion onto fibronectin-coated substrates (Pierschbacher and Ruoslahti, 1984; 
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Fig. II-13. Multiple sequence alignment of the integrin-binding site of nephronectins from different 
vertebrate species. Amino acid sequences in the RGD-containing linker segment of nephronectins from 
various vertebrate species were aligned by Clustal W (Thompson et al., 1994). The RGD and EIE motifs 
are highlighted in black and dark gray boxes, respectively. Two phenylalanine residues are labeled in light 
gray boxes. 
 
Akiyama and Yamada, 1985; Manabe et al., 1997). In this regard, the 23-mer peptide 
containing both the RGD motif and the LFEIFEIER sequence fully mimics the 
interaction of nephronectin with α8β1 integrin and completely blocks the interaction at a 
concentration of 10 nM, but has no inhibitory effects on the interaction between 
fibronectin and α5β1 integrin (Y.S., unpublished observation). Given the remarkable 
potency of the 23-mer peptide in specifically blocking the nephronectin-α8β1 integrin 
interaction at nanomolar concentrations, the 23-mer peptide represents a promising probe 
for elucidating the biological functions of this integrin-ligand interaction in both 
physiological and pathological processes.  
In summary, I have shown that nephronectin is the most preferred high-affinity ligand 
for α8β1 integrin and that the specificity and high-affinity binding toward the integrin 
are fully recapitulated by a 23-amino acid residue fragment harboring both the RGD 
motif and the LFEIFEIER sequence, the latter serving as an auxiliary site that ensures the 
specific high-affinity binding of nephronectin to α8β1 integrin in concert with the RGD 
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motif. Although the mechanism by which the synergy site potentiates the integrin binding 
affinity remains to be validated by determination of the 3D structure of the fully active 
RGD-linker segment at the atomic level, these results provide, for the first time, the 
molecular basis of the specific interaction between nephronectin and α8β1 integrin, and 
highlight the bipartite nature of the integrin recognition site of nephronectin. 
 108 
General Discussion 
 
To elucidate the molecular characteristics and the domain functions of nephronectin, I 
established recombinant expression systems to prepare and purify full-length 
nephronectin and its domain deletion mutants, and examined their activities to bind to a 
panel of GAG chains as well as α8β1 integrin, one of the known receptors for 
nephronectin. I demonstrated that nephronectin had potency in binding to 
heparin/heparan sulfate and chondroitin sulfate-E through its MAM domain and five 
EGF-like repeats, respectively. In addition, I tried to determine the minimal amino acid 
sequences of nephronectin required for potent binding to α8β1 integrin, and found that 
the α8β1 integrin required a bipartite binding site consisting the RGD motif and the 
LFEIFEIER sequence, the latter serving as an auxiliary binding site that enhances the 
activity to bind to α8β1 integrin. The results obtained in this study should provide new 
insights into the physiological functions of nephronectin. 
In this chapter, I discuss the problems and prospects for purification and functional 
characterization of nephronectin and integrins, and integrate the descriptive data to 
understand how nephronectin can contribute to regulate kidney morphogenesis along 
with α8β1 integrin and how RGD-binding integrins selectively recognize their ligands.  
 
Problems and Prospects for Purified Nephronectin and Integrins 
To identify molecular characteristics of nephronectin, I purified nephronectin as 
recombinant proteins. However, there are some problems and questions with respect to 
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the methods of purification. 
 
Problems in purification of nephronectin as a recombinant protein: Does recombinant 
nephronectin reflect physiological functions?  
In this study, I purified recombinant nephronectin as an intact form. A FLAG tag was 
added to the C-terminus of nephronectin to facilitate affinity purification by using 
anti-FLAG mAb and FLAG peptide. This method allows me to purify recombinant 
nephronectin without denaturing processes. Although many of ECM proteins had been 
purified as recombinant proteins and shown to exhibit biological properties similar to 
native proteins, recombinant nephronectin has some problems. First, the recombinant 
nephronectin contains a FLAG tag at its C-terminus. Since a FLAG tag consists of many 
acidic residues and was added in the vicinity of the MAM domain that is rich in basic 
amino acid residues, it could be possible that the FLAG tag has some effects on 
structures of the MAM domain and/or reduces heparin-binding activities of nephronectin. 
Second, since nephronectin was purified by affinity chromatography with anti-FLAG 
mAb interacting with C-terminal FLAG tag, the purified nephronectin could contain 
N-terminally processed forms and intact nephronectin. Third, recombinant nephronectin 
should be over-glycosylated compared with native nephronectin. The apparent molecular 
mass of purified recombinant nephronectin expressed in 293-F cells was ~120 kDa under 
reducing conditions, whereas that expressed in 293-T cells was ~100 kDa (data not 
shown). Moreover, nephronectin in newborn kidney extracts had been shown to migrate 
at 70~90 kDa upon SDS-PAGE (Brandenberger et al., 2001). These apparent 
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discrepancies in molecular masses of nephronectin should arise from differences in cell 
types expressing nephronectin, since the structure and the number of oligosaccharides 
attached depend on the cell type, its enzymatic machinery, its developmental stage, and 
its nutritional or pathological state (Durand and Seta, 2000). All of these problems 
demonstrate that, to further analyze the authenticity of recombinant nephronectin, it is 
necessary to purify endogeneous nephronectin and to compare it with recombinant 
nephronectin. In this study, I showed that recombinant nephronectin had potency to bind 
to heparin and chondroitin sulfate-E and to form homo-multimers. These observations 
raise a possibility that the combination of chromatographies, including heparin, 
chondroitin sulfate-E, and gel filtration chromatographies, may enable me to purify 
endogenous nephronectin. 
 
Potential problems in purification of integrins as recombinant proteins: a possibility that 
the C-terminal clasp diminishes the binding activity of recombinant integrins 
In this study, I expressed and purified integrins as recombinant proteins. The 
recombinant integrins consist of extracellular regions of α and β subunits conjugated 
with ACID and BASE peptides, respectively, to form αβ heterodimers with an interchain 
disulfide bond. The feasibility of this strategy for the expression of recombinant integrins 
has previously been demonstrated for many integrins including α3β1, α4β1, α5β1, α6β1, 
and αVβ3 (Lu et al., 2001; Takagi et al., 2001; 2002a; 2002b; Nishiuchi et al., 2006). 
The activities of these recombinant integrins have been shown to principally reproduce 
those of integrins endogenously expressed on the cell surface and purified from tissue 
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extracts. Although the recombinant integrins appear to have activities as well as 
endogenous ones, they have a potential drawback: the artificial constraint at the 
C-termini of integrins. Whereas the N-terminal head region of integrins has been shown 
to make direct contacts with their ligands, the C-terminal tail region is also implicated in 
the interaction by regulating the activities of integrins. It is well known that integrins 
change their conformation according to their activation/inactivation states. An increased 
number of studies have established that the inactivated integrin exhibits bent, V-shape 
conformation with its head region faced toward plasma membranes, while ligand binding 
induces a large-scale conformational rearrangement in which the integrin extends with a 
“switch-blade” like motion and moves tail regions of α and β subunits apart from one 
another with a “leg spread” like motion (Takagi et al., 2002b; Luo and Springer, 2006; 
Luo et al., 2007). The “leg spreading” of integrin tail region has been shown to be 
involved in integrin activation. The membrane-proximal cytoplasmic regions of integrin 
α and β subunits are thought to interact with each other by forming a salt bridge, 
preventing integrin activation by stabilizing the low-affinity state (Hughes et al., 1996; 
Banno and Ginsberg, 2008). Mutations or deletions in the membrane-proximal sequences 
that break the salt bridge induce integrin activation (O'Toole et al., 1991; 1994). 
Consistently, the binding affinities of recombinant αVβ3 integrin were further increased 
by cleavage of the C-terminal ACID-BASE coiled-coil region, even though the integrin 
was activated by addition of Mn2+ (Takagi et al., 2002b). These data together strongly 
indicate not only that the interaction between the α and β membrane-proximal regions 
maintains the integrins in an inactivation state, but also that the C-terminal constraint 
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lessens the activities of recombinant integrins to bind to their ligands. Thus, there is no 
assurance that the activity of recombinant α8β1 integrin used in this study is equivalent 
to that of endogenous one. Indeed, the results of solid-phase binding assays using 
recombinant α8β1 integrin were somewhat different from those of cell adhesion assays 
using α8β1 integrin expressed on cell surfaces. In solid-phase assays, the affinity of 
LS/378-403, which possesses both the RGD and EIE motifs, was >10-folds higher than 
that of LS/378-393, which possesses only the RGD motif (Fig. II-5 and Table II-1), 
whereas in cell adhesion assays the activity of LS/378-403 was only ~4-folds higher than 
that of LS/378-393 (Fig. II-10). Although the activities of recombinant α8β1 integrin 
cannot be simply compared with those of α8β1 integrin expressed on cells because of the 
differences in the assay systems, this observation again raises a possibility that the 
activity of recombinant α8β1 integrin is not equivalent to those of endogenous one. 
To address the problems of the differences between the recombinant and endogenous 
integrins, it is desirable to purify endogenous α8β1 integrin and to compare ligand- 
binding activities of endogenous integrins with those of recombinant ones. So far, a 
variety of endogenous integrins, including α5β1, αVβ3, αVβ5, αIIbβ3, α3β1, and α6β1, 
had been purified from human tissues or cell lines (Pytela et al., 1985a; 1985b; Lam et al., 
1989; Smith et al., 1990; Nishiuchi et al., 2003). The ligand-mimetic RGD peptides have 
been used for purifying RGD-recognizing integrins under non-denaturing conditions. 
Based on my experiments, α8β1 integrin preferentially binds to short amino acid 
sequences containing the RGD and the EIE motifs but showed only marginal affinity for 
that containing only the RGD motif. This result raises a possibility that a column 
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conjugated with peptides containing both the RGD and the EIE motifs enables me to 
selectively purify α8β1 integrin from tissue extracts. To verify the authenticity of 
recombinant α8β1 integrin used in this study, the activities of the recombinant α8β1 
integrin should be compared with that of α8β1 integrin purified from tissue extracts or 
cell lines. 
  
Problems and Prospects for Functional Characterization of 
Nephronectin and Integrins 
To characterize the molecular functions, I mainly exploited solid-phase binding assays 
in which the analytes were applied to plastic plates coated with ligands. In some cases, I 
determined dissociation constants of the interaction from the data of solid-phase binding 
assays. Here, I focused on the problems of experimental systems for functional 
characterization of nephronectin and integrins. 
 
Problems with integrin binding assays in the presence of Mn2+ 
It is well known that integrins require bivalent cations to interact with their ligands. 
Bivalent cations have multiple effects on integrin functions, including modulation of 
ligand binding activities and specificities (Kirchhofer et al., 1990). In this study, binding 
activities of integrins were assessed in the presence of Mn2+ ion, since Mn2+ is known to 
enhance the binding affinities of integrins to their ligands. The presence of Mn2+ enables 
me to sensitively detect the bindings of integrins, and therefore to measure dissociation 
constants of the interaction with a variety of ligands. However, there is a problem 
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concerning the presence of Mn2+ ion. First, the concentration of Mn2+ ion in the assay 
conditions was much higher than that in the physiological conditions. The concentrations 
of Mn2+ in tissues were estimated to be in the range of 1-14 µM (Smith et al., 1994), 
whereas the binding assays of integrins were performed in the presence of 1 mM Mn2+, 
far exceeded the physiological concentrations. Second, manganese ions are not the ions 
that bind to integrins in vivo. Physiologically, Ca2+ and Mg2+ ions are more abundant than 
Mn2+, and have been shown to coordinate the divalent cation-binding sites of integrins 
(Xiao et al., 2004). Third, in some cases, the change of coordinating divalent cations 
alters the binding specificities of integrins. For example, αVβ3 integrin has been shown 
to interact with fibrinogen in the presence of Mn2+, but not in the presence of Ca2+ (Smith 
et al., 1994). The binding specificity in the presence of Mn2+ may be attributed to the 
enhancement of the binding affinity of integrins toward low-affinity ligands, since Mn2+ 
and Mg2+, but not Ca2+ ions are known to increase the binding affinities of integrins 
(Smith et al., 1994; Mould et al., 1995). Taken together, these observations raise a 
possibility that the addition of Mn2+ ion might cause an unfavorable effect on the binding 
affinity and specificity of integrins. 
Despite the fact that the presence of excess Mn2+ may be a non-physiological 
condition, the binding activity of recombinant α8β1 integrin clearly depends on the 
presence of the EIE motif on the C-terminal side of the RGD motif, irrespective of the 
class of divalent cations, i.e., Ca2+/Mg2+ or Mn2+. Although the activities are less 
prominent, the recombinant α8β1 integrin is capable of interacting with its known 
ligands, i.e., fibronectin and vitronectin, in the presence of Mn2+ ion (Schnapp et al., 
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1995; Denda et al., 1998a). These observations strongly suggest following two points 
that; 1) the binding specificities of recombinant α8β1 integrin follow that of 
physiological α8β1 even in the presence of Mn2+, and; 2) the EIE motif-dependent 
interaction of α8β1 integrin is physiological, not an artifact caused by the addition of 
non-physiological Mn2+ ion. The Mn2+ ion was also used to determine the ligand-binding 
specificities and affinities of laminin-binding integrins (Nishiuchi et al., 2006). The 
specificities of laminin-binding integrins have been shown to remain unchanged 
regardless of the class of divalent cations. Moreover, the binding affinities of laminins to 
laminin-binding integrins are in good agreement with the cell-adhesive activities of 
individual laminins (Fujiwara et al., 2004). Therefore, integrin-binding assays in the 
presence of 1 mM Mn2+ are considered to reflect physiological binding activities of 
integrins to their ligands, even though the presence of Mn2+ might be a non-physiological 
condition. 
 
Problems in determination of dissociation constants by solid-phase binding assays 
To quantitatively assess the interaction of α8β1 integrin with nephronectin, 
solid-phase binding assays were used to measure apparent dissociation constants for 
binding of α8β1 integrin to its ligands. The determination of Kd values by solid-phase 
assays premises that, once the formation of integrin-ligand complex reached equilibrium 
states, the complex is never disrupted throughout the subsequent procedures, including 
washing plates and incubation with anti-Velcro antibody and streptavidin. However, there 
is a striking contradiction. The complex formation and dissociation occur simultaneously 
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during the incubation of proteins with ligands. When the plates coated with ligands were 
washed to remove unbound integrins, the dissociation of the complex become 
predominant rather than the formation of the complex, therefore the condition was no 
longer at the equilibrium state. As a result, the integrins bound to ligand-coated plates 
were detected under the non-equilibrium state, thus the calculated Kd values was not the 
“real” dissociation constants. 
Another problem for solid-phase binding assays is that the assays are able to only 
determine the affinity of the interactions. This means that the affinity of protein-protein 
interaction ignores the kinetic nature of complex formation and dissociation (Schreiber, 
2002). The kinetic analyses of protein interactions provide not only the affinities but also 
the association and dissociation rate of the interaction. In general, the association rate is 
limited by diffusion of molecules, geometrical constraints (accessibilities) of the binding 
sites, and electrostatic forces implicated in a long-range electrostatic steering (Schreiber, 
2002), therefore the rate is mainly affected by residues near, but outside, the interaction 
site (Clackson and Wells, 1995). On the other hand, the dissociation rate is limited by 
stabilities of the complex, and therefore affected by residues that are part of protein- 
protein interfaces (Clackson et al., 1998; Wu et al., 2002). Based on the reports described 
above, kinetic analyses of the interaction, together with mutational analyses, lead to 
elucidation of amino acid residues involved in the interaction in or outside the protein- 
protein interfaces. In my study, I calculated dissociation constants of the interaction of 
α8β1 integrin with mutant proteins of the linker segment of nephronectin, and found that 
the EIE motif increases the binding affinity of nephronectin to α8β1 integrin, However, 
 117 
the mechanisms by which the EIE motif enhances the binding affinity remain obscure. 
Thus, kinetic analyses of the interactions are required to better understand how the EIE 
motif is involved in the interaction of α8β1 integrin with nephronectin. 
 
Physiological Roles of Nephronectin in Mouse Development 
In this study, I investigated molecular functions of nephronectin, and revealed the 
following two points: 1) nephronectin has a potency to bind to highly sulfated GAG 
chains (Chapter I), and: 2) nephronectin preferentially binds to α8β1 integrin in the RGD 
and the EIE motif-dependent manner (Chapter II). Here, I integrate the data to 
understand how nephronectin can contribute to regulate mouse development, especially 
kidney morphogenesis along with α8β1 integrin. 
 
The role of nephronectin in regulation of mesenchymal cells 
In epithelial tissues, basement membranes beneath the epithelium are specialized 
ECMs directly attached to epithelial cells. Consequently, cell-adhesive proteins in the 
basement membrane have been thought to regulate epithelial cell behaviors, such as 
survival and proliferation, through interacting with integrins expressed on the epithelium. 
It should be noted that, despite the localization of nephronectin in the basement 
membranes, several lines of evidence support the idea that nephronectin regulates 
mesenchymal but not epithelial cell behaviors. For example, the receptor for 
nephronectin is α8β1 integrin, which is predominantly expressed in mesenchymal cells 
of developing kidney (Brandenberger et al., 2001). The phenotypes of mice deficient in 
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nephronectin expression quite resemble that of α8 integrin-null mice (Muller et al., 1997; 
Linton et al., 2007), strongly suggesting that nephronectin binds to α8β1 integrin with 
high selectivity, and that physiological functions of nephronectin are closely linked to 
those of α8β1 integrin. Furthermore, metanephric mesenchymal cells but not ureteric bud 
epithelial cells failed to differentiate appropriately in the nephronectin-null mice, 
resulting in the failure of GDNF expression in the metanephric mesenchymes (Linton et 
al., 2007). It is interesting to note that the interaction of nephronectin with mesenchymal 
cells is possibly not restricted to kidney development. As far as my observations are 
concerned, nephronectin are deposited onto basement membranes in developing hair  
 
Fig. D-1 Localization patterns of nephronectin and integrin α8 subunit in mice embryos. Sections of 
an oral cavity at E14.5 (A) and a hair follicle at E16.5 (B) mice embryos were stained with antibodies 
against the extracellular domain of the integrin α8 subunit (red) and nephronectin (green). Nuclei were 
visualized by staining of Hoechst 33342 (blue). Mesenchymal cells surrounding the tooth germ (A) and 
beneath the tip of the hair follicle (B) express the integrin α8 subunit. Arrowheads indicate co-localization 
of nephronectin with α8 integrin. Scale bar, 20 µm. 
A! B!
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follicles and tooth germs, while mesenchymal cells surrounding the hair follicles and 
tooth germs express α8β1 integrin, whose distribution patterns are partly overlapped 
with those of nephronecin (Fig. D-1). Furthermore, as shown in Figs. 11 and D-1 (pages 
27 and 118, respectively), the mesenchymal cells expressing α8β1 integrin appear to be 
aggregated, forming mesenchymal condensations, thus the region in which nephronectin 
co-localizes with α8 integrin is where epithelia and mesenchymes reciprocally interact. 
Together with the epithelium-specific expression of nephronectin (Brandenberger et al., 
2001; Tumbar et al., 2004), the observations above strongly suggest that the interaction 
of nephronectin with mesenchymal α8β1 integrin is a sort of epithelial-mesenchymal 
interactions regulating mesenchymal cell behaviors. Moreover, the observations also 
provide new insights into the roles of basement membranes in epithelial-mesenchymal 
interactions during tissue development. 
 
Possible roles of nephronectin in epithelial-mesenchymal interaction 
The accumulating evidence supports the role of nephronectin as a regulator of 
mesenchymal cell behaviors. Then, how can nephronectin regulate the epithelial- 
mesenchymal interactions? One possible explanation is that the specific, high affinity 
interaction of α8β1 integrin with nephronectin may anchor mesenchymal cells 
expressing α8β1 integrin to the mesenchymal side of basement membranes where 
epithelial-mesenchymal interactions take place (Fig. D-2A). Because several studies, 
together with my observation, have demonstrated that α8β1 integrin inhibits migration of 
cells adhering to RGD-containing ECM proteins even though the integrin promotes cell 
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Fig. D-2 Schematic models for nephronectin in epithelial-mesenchymal interaction. A, a 
“nephronectin-glue” model. (a) The loose mesenchyme beneath the epithelium adheres to nephronectin at 
the mesenchymal side of basement membranes. (b) Nephronectin stably anchors the mesenchyme through 
the interaction with α8β1 integrin. (c) Since the basement membrane concentrates soluble factors, both the 
epithelium and mesenchyme receive the factors efficiently, owing to the mesenchymal adhesion to 
nephronectin. (d) After all, the epithelium and mesenchyme differentiate to form individual tissues. B, a 
“promotion of survival and proliferation by nephronectin” model. (a) Nephronectin binds to α8β1 integrin 
expressed on the mesenchyme that transmits signals to induce epithelial cell differentiation. (b) The 
interaction of α8β1 integrin with ligands has been shown to promote cell survival and proliferation via 
PI3K-PKB/Akt and MAPK pathways. (c) The adhered cells are able to survive and proliferate, thereby 
enhance the inductive signals. (d) After all, the cells proliferate and differentiate to form individual 
tissues. 
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adhesion to them (Bieritz et al., 2003; Zargham et al., 2007; Benoit et al., 2009; K. 
Morimitsu and Y. Sato, unpublished observation), the mesenchymal cells adhering to 
nephronectin through the α8β1 integrin may be kept staying at the adhesion site, and 
therefore are positioned face-to-face with the epithelium. Juxtaposition of epithelium and 
mesenchyme should enhance the efficiency of reciprocal signaling between them, since 
epithelial-mesenchymal interactions are mainly mediated by multiple soluble factors, 
including GDNF, Wnt, and FGFs (Schedl, 2007), which are sequestered by ECMs to 
form concentration gradients (Kispert et al., 1996; Allen et al., 2001; Barnett et al., 2002). 
Thus, the function of nephronectin in epithelial-mesenchymal interaction should be to 
facilitate “gluing” particular cells, i.e., α8β1-expressing mesenchymes, to regions where 
soluble factors secreted by epithelium are enriched. 
Accumulating evidence also supports another possible explanation for the role of 
nephronectin in epithelial-mesenchymal interaction; nephronectin may be required for 
mesenchymal cell survival (Fig. D-2B). For example, the interaction of α8β1 integrin 
with fibronectin has been shown to stimulate the activation of phosphatidylinositol 
3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways (Farias et al., 
2005). The expression of α8 integrin subunit has been shown to prevent cells from 
apoptosis (Farias et al., 2005; Hartner et al., 2008; Benoit et al., 2009). The mice with 
homozygous null mutation of α8 integrin gene also support this explanation, since the 
mice exhibit degeneration of the metanephric mesenchymes at embryonic day 13.5, due 
to the absence of the direct interaction between the mesenchyme and ureteric bud 
epithelium (Muller et al., 1997). Moreover, it is of interest to note that interstitial ECM 
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proteins, including fibronectin and collagens, are absent from condensing mesenchyme 
even though these ECMs deposit in metanephric mesenchymes before the mesenchymal 
condensation is formed (Ekblom, 1981; Mounier et al., 1986), suggesting that, to avoid 
anoikis, the condensing mesenchymes have to use nephronetin as a scaffold. Thus, owing 
to the localization of nephronectin at the site of epithelial-mesenchymal interactions, the 
metanephric mesenchymes adhering to nephronectin may be able to survive and 
proliferate, thereby continuously secreting soluble factors, such as GDNF, for ureteric 
bud epithelium and thereby induce differentiation of the epithelial cells. 
 
Ligand-Recognition Mechanisms of Integrins that Bind to the RGD 
Motif 
Previous studies, as well as this study, demonstrate that the RGD-binding integrins 
require both the RGD motif and auxiliary site to exert selective and high-affinity binding 
to their physiological ligands. However, it is still unclear why and how the RGD-binding 
integrins require the auxiliary site to selectively interact with their ligands. Here, I 
discuss the possible mechanisms by which the RGD-binding integrins interact with the 
auxiliary binding sites of the ligands. 
 
The functional consequence of the auxiliary binding sites in ligand recognition by the 
RGD-binding integrins 
In vertebrates, 4 α and 5 β integrin subunits have been identified to form 8 types of 
RGD-binding integrins. Although the RGD motif primarily determines the specificities 
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of ligand binding to the RGD-binding integrins, it is undoubted that the auxiliary binding 
sites residing outside the RGD motif also define the specificities and affinities of 
individual integrins to their ligands (Ruoslahti, 1996; Takagi, 2004). Then, how 
individual RGD-binding integrins recognize the differences of the auxiliary binding site 
of ligands? It is worth considering that the properties of auxiliary binding sites identified 
so far are obviously different from each other. For example, the synergy site of 
fibronectin, known to enhance the binding affinity to α5β1 integrin, is comprised of 
PHSRN sequence and several basic residues (Aota et al., 1994; Redick et al., 2000). The 
auxiliary binding site to αVβ6 integrin is the LXXL/I sequence, in which two 
hydrophobic residues have been shown to interact with the αVβ6 integrin (DiCara et al., 
2007). As shown in Chapter II, two acidic residues of the EIE motif are indispensable for 
high-affinity interaction of nephronectin with α8β1 integrin. Taken together, these 
observations suggest that the individual RGD-binding integrins may discriminate the 
specific sequences of auxiliary sites, containing acidic, basic, or hydrophobic properties, 
in the vicinity of the RGD motif, thereby specifically interacting with the physiological 
ligands of individual RGD-binding integrins. 
If the physiological ligands for RGD-binding integrins possess characteristic 
sequences to increase the binding affinity and specificity to the individual integrins, the 
integrins should also possess counterparts recognizing the auxiliary binding site of the 
ligands. In fact, amino acid sequences in the vicinity of the ligand-binding site, which is 
located at upper or side faces of β-propeller domain of integrin α subunit, show 
significant diversity among the RGD-binding integrins. The diversity is apparent when  
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Fig. D-3 Predicted structures of the head region of α8β1 integrin. A, ribbon models of β-propeller 
domain of α8 integrin (a, side view) and head domain of α8β1 integrin (b, upper view) are created using 
the crystal structure of αVβ3 integrin (PDB ID; 1jv2) as the template. The models were predicted with the 
SWISS-MODEL (http://swissmodel.expasy.org/; Arnold et al., 2006) and fine-tuned by energy 
minimization with Swiss PDB viewer. Dashed circles indicate the loops that exhibit significant divergence 
among different α subunits. The amino acid sequences comprising the loops are shown in upper margin. B, 
molecular surfaces of α8β1 (left) and α5β1 (right) integrins were generated with Chimera, colored by 
electrostatic potentials from -15 (red) to +15 (blue) kcal/mol⋅e. The viewpoints were the same as in A-(b). 
Dashed circles represents approximate locations of the RGD-docking site.  
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the amino acid sequences of the β-propeller domain of α8 integrin are compared with 
those of α5 integrin (Fig. D-3A). As discussed in Chapter II, the cluster of basic residues 
are located at the upper or side faces of α8 integrin β-propeller, whereas α5 integrin 
possesses the cluster of acidic residues at the equivalent sites of basic cluster in α8 
integrin. The significant divergence in charge distribution patterns is evident in predicted 
surface electrostatic potentials of α8β1 and α5β1 integrins (Fig. D-3B). Given that the 
auxiliary sites of fibronectin and nephronectin are mainly comprised of basic and acidic 
residues, respectively, it is tempting to speculate that the acidic and basic clusters of 
integrin α5 and α8 subunit, respectively, interact with the auxiliary binding sites of the 
ligands, thereby increasing the binding specificity as well as affinity to the physiological 
ligands. 
 
Possible mechanisms for the involvement of the auxiliary binding site in the interaction 
with the RGD-binding integrins 
Although it is undoubted that the auxiliary binding sites increase the binding affinity 
to the individual integrins, the mechanisms by which the auxiliary sites increase the 
affinity are still unclear. Given that increases in the affinity of protein-protein 
interactions are achieved by increasing the association rate, decreasing the dissociation 
rate, or both of them, the auxiliary binding sites are thought to enhance the binding 
activities to the individual integrins through affecting the association and/or dissociation 
rates. Here, I propose the following two models that account for molecular mechanisms 
underlying the enhancement of the affinities by the auxiliary binding sites. 
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One possible (and simple) model for the role of the auxiliary binding sites is their 
direct interaction with integrins. In this model, the auxiliary site is hypothesized to reside 
within the binding interface of the complex, thereby decreasing the dissociation rate by 
stabilizing the final complex between the integrin and ligand (Fig. D-4A). Thus, the RGD 
tripeptide motif fits into the RGD-docking site at the top of head domain of integrins, 
resulting in subsequent formation of salt bridges between the auxiliary site and integrin. 
This model is in agreement with the structure of α5β1 integrin-fibronectin complex 
deduced from solution X-ray scattering (Mould et al., 2003), and easy to understand how 
the auxiliary sites enhance the binding affinities. Based on this model, a peptide modeled 
after the auxiliary binding site should partially inhibit the interaction of integrins with 
their ligands. However, previous studies, as well as my study, have revealed that the 
peptides containing only the auxiliary site is barely inhibitory (Aota et al., 1994). The 
reason why the peptides including the auxiliary site of the ligand failed to inhibit the 
interaction of integrins remains to be further elucidated. 
The other possible model is that the acidic (or basic) portion of the auxiliary site and 
the basic (or acidic) portion of the head region of integrin stabilize the initial encounter 
complex between the integrin and ligand via long-range electrostatic interaction (Fig. 
D-4B). Therefore, the binding interface of integrin is located in the vicinity of the RGD 
motif, making the motif easily to bind to the RGD-docking site of integrin. In this model, 
the auxiliary site is hypothesized not to be part of specific protein-protein interaction but 
to be an “attractant” of the interaction, thereby increasing the binding affinity to integrin 
through affecting the association rate. This model seems to be more reasonable than the  
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Fig. D-4 Possible mechanisms of the bipartite recognition of ligands by RGD-binding integrins. A, a 
“stabilization of final complex” model. The RGD motif fits into a narrow groove between the head 
domains of α and β subunits of integrin (upper). Thereafter, the auxiliary binding site interacts with the 
β-propeller domain of α subunit (lower), stabilizing the final complex (and thereby decreasing the 
dissociation rate of the interaction). B, a “stabilization of initial encounter complex” model. The upper and 
side faces of β-propeller domain of integrin α subunit interact with the auxiliary site of ligand through 
long range electrostatic steering (upper), keeping the RGD motif in the vicinity of the RGD-docking site 
of integrin. Thus, theRGD motif easily fits into the narrow groovebetween the α and β subunit (middle). 
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former model, since in this model the peptides modeled after the auxiliary site should be 
barely inhibitory, consistent with the results obtained in this study (Fig. II-7; page 91). 
The possibility of this model was assessed using α5β1 integrin and fibronectin fragment 
(Takagi et al., 2003). Takagi et al. demonstrated that the mutation of synergy site of 
fibronectin primarily affected the association rate, resulted in 26-fold decrease. By 
contrast, the dissociation rate exhibited only 2-fold increase in this mutant. Moreover, the 
observation of α5β1-fibronectin fragment complex by electron microscopy revealed that 
α5β1 integrin did not interact with the synergy site of fibronectin, suggesting that the 
synergy site of fibronectin does not contribute to the stability of final α5β1 
integrin-fibronectin complex. Given that α8β1 and αVβ6 integrins require acidic and 
hydrophobic residues, respectively, to interact with their physiological ligands, it is 
tempting to speculate that the auxiliary sites stabilize the initial encounter complexes 
through electrostatic or hydrophobic interactions, thereby enhancing the affinities and 
providing the specificities of the individual integrins to interact with their ligands. To 
determine the role of auxiliary sites in the interaction with integrins, further studies, 
particularly analyses of three-dimensional structure of integrin-natural ligand complexes, 
will be required. 
 
Studies for spatiotemporally regulated basement membrane proteins are just beginning, 
and their functions have been poorly known. Nephronectin is one of the spatiotemporally 
regulated basement membrane proteins, and has unique functions: the activities to bind to 
highly sulfated GAG chains and α8β1 integrin. Although much progress has been made 
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in understanding of the molecular functions of nephronectin, there are still many 
questions to be answered. Namely, how the bipartite site of nephronectin is recognized 
by α8β1 integrin? What kinds of signaling pathways does nephronectin transmit to cells 
through α8β1 integrin? What are the physiological functions of nephronectin in vivo? 
When these questions are answered, not only the functions of nephronectin along with 
α8β1 integrin but also the physiological roles of spatiotemporally regulated basement 
membrane proteins will be better understood. 
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